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2 SUMMARY 
Background: Pelvic girdle pain (PGP) is a frequently reported musculoskeletal disorder 
that impacts the activity level in pregnant women. However, the prevalence and severity of 
this condition during and after pregnancy is unsure. To gain a better insight into underlying 
factors potentially influencing PGP, it is of interest to examine how pelvic girdle pain and 
disability are associated with responses to some frequently used clinical tests.  
The reported prevalence of PGP in pregnancy varies considerably in previous 
studies. Even though most women with PGP in pregnancy seem to recover shortly after 
delivery, it has been reported that a considerable number of women develop chronic PGP, 
resulting in pain and functional problems postpartum. Therefore, aiming at limiting negative 
consequences of PGP during and after pregnancy, it is important to identify risk factors for 
development of PGP in pregnancy as well as for sustained PGP postpartum. Previous 
studies have reported that typical risk factors for development of PGP include history of low 
back pain before pregnancy and PGP in previous pregnancies. However, it would be of 
interest to also identify more clinically relevant factors that could possibly be targeted by 
treatment strategies.   
A main focus in the clinical examination of women with PGP is to distinguish 
between pain located in the pelvic area or in the low back area. However, in addition, it is 
also important to explore the associations between the responses to frequently used pelvic 
tests and the severity of PGP during and after pregnancy.    
 
Aims: The main objective of this thesis was to explore factors related to pelvic girdle pain 
and disability during and after pregnancy, and to estimate the prevalence of PGP at different 
times. The specific research objectives were: to examine the associations between the 
responses to clinical tests and disability in gestation week 30. Furthermore, to identify risk 
factors for development of PGP and disability during pregnancy as well as for sustained 
PGP and disability 12 weeks postpartum. 
 
Material and methods: A total of 326 women recruited from four maternity care units in 
the Oslo area gave informed consent for participation in the study. Data were collected by 
questionnaires and clinical examinations at inclusion (mean gestation week 15), in gestation 
week 30, and 12 weeks postpartum. Prospective and cross-sectional designs (gestation week 
30) were used and the response variables were disability (measured by the disability rating 
index, DRI) and pain intensity (measured by visual analogue scale, VAS). Variables 
identified in previous studies (socio-demographical and psychological factors) as well as 
self-reported pain locations defined from pain drawings and responses to clinical tests were 
used as explanatory variables (risk factors in paper II and III). The data were analyzed using 
different statistical approaches, including tests for comparisons of groups and bivariate and 
multivariable regression analyses for associations. 
 
Results: Prevalence of self-reported PGP was 35%, 62% and 31% at inclusion, gestation 
week 30, and 12 weeks postpartum respectively. Large variation in disability (DRI) was 
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found at all times independently of the presence or absence of PGP. Pregnancy itself 
resulted in increased disability, and PGP gave an additive effect. 
In the cross-sectional study of data from gestation week 30 multivariable analyses 
resulted in strong associations between pain locations within the pelvic area, responses to 
the posterior pelvic pain provocation (P4) test and the active straight leg raise (ASLR) test 
and disability.  
Among the clinical factors assessed in early pregnancy, self-reported pain locations 
in the pelvic area, response to the P4 test, and sum of positive pain provocation tests were 
risk factors for disability and pain intensity in gestation week 30. In addition distress was 
associated to disability.  
Among the clinical factors assessed in gestation week 30, the sum of positive pain 
provocation tests was a risk factor for both disability and pain 12 weeks postpartum. 
Furthermore, number of pain sites in other areas of the body was a risk factor for pain 
intensity 12 weeks postpartum and pre-pregnancy low back pain was a risk factor for 
disability. Pre-pregnancy body mass index was associated with both disability and pain 
intensity and response to the ASLR test was associated with disability, though none of them 
significantly. 
 
Conclusions: The high prevalence of PGP during and after pregnancy indicates that there is 
a need for attention by health care providers. The large variation in disability seen among 
the women at all times regardless of the presence or absence of PGP shows that pregnancy 
itself impacts function. Furthermore, the results support the common clinical experience that 
there is a large variation in affliction among women with PGP. The different risk factors 
identified for development of PGP in pregnancy and for sustained PGP 12 weeks 
postpartum emphasize a need to distinguish between these phases. The identification of 
clinical risk factors for PGP is a novel finding and probably of importance in further 
development of treatment and prevention strategies 
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5 DEFINITIONS and TERMINOLOGY 
5.1 Pelvic Girdle Pain (PGP) 
In this thesis PGP is understood as musculoskeletal pain located within the pelvic area (i.e. 
below the lumbosacral junction and above the gluteal folds) that develops in relation to 
pregnancy. The participants were asked if they had pain in the pelvic area, and eventually 
where the pain was located. No Norwegian terms synonymous with PGP were used either in 
the questionnaires or in the examinations. Nevertheless our understanding of PGP is in 
accordance with the definition from the European guideline group of 2008: 
“Pelvic girdle pain (PGP) generally arises in relation to pregnancy, trauma, arthritis 
and osteoarthritis. Pain is experienced between the posterior iliac crest and the gluteal 
fold, particularly in the vicinity of the sacroiliac joints. The pain may radiate in the 
posterior thigh and can also occur in conjunction with/or separately in the pubic 
symphysis.’’ 106 
  
5.2 Low Back Pain (LBP) 
In this thesis LBP is understood as pain in the lower back, located above the lumbo-sacral 
junction with or without radiation in the leg(s). Hence our understanding of LBP is narrower 
than definitions being used by others,100;109 but in accordance with a previous study of PGP.69 
 
5.3 Lumbopelvic pain 
When no specific distinction is made between LBP and PGP, the condition is referred to as 
lumbopelvic pain in keeping with several studies,87;114 i.e. this definition includes both PGP 
and LBP. To our understanding, this definition is in accordance with the definition of low 
back pain used in the European guidelines from 2006: 
“Low back pain is defined as pain and discomfort, localized below the costal margin 
and above the inferior gluteal folds, with or without leg pain.” 100 
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5.4 Disability 
In this thesis the term disability is used in the meaning of reduced physical function (e.g. 
difficulties doing activities like outdoor walks, climbing stairs, running, carrying a bag, etc.)   
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6 BACKGROUND 
Before I started my academic career, I had about 20 years of experience as a physiotherapist 
and manual therapist in clinical practice, treating patients mainly with musculoskeletal 
disorders. During these years, I have met many women suffering from pain in the pelvic area 
during pregnancy and after delivery. The complexities in their stories as well as in their 
clinical pictures gave me a number of questions to bring along into this field of research.  
The main goal for treatment using physiotherapy and manual therapy is to relieve pain 
and to restore or maintain the patients’ physical function.111 When treating the women with 
pregnancy related pain in the pelvic area, I experienced that my treatment often fell short, 
without understanding why and also that several women did not recover as expected after 
delivery. Their ability to take part in daily activities and to earn a living could be reduced. My 
question was: Why did some women develop chronic problems, while others recovered?  
My clinical experience indicated that musculoskeletal pain in the pelvic area seemed 
to have a very different influence on the women’s lives and that the condition was complex to 
understand and difficult to treat. I ended up being curious about the course of pain in the 
pelvic area during and after pregnancy, and I wanted to know more about risk factors for 
developing such pain as well as for non-recovery after delivery. Most of all I lacked and 
wanted more knowledge about risk factors that we really could manage - or treat - in clinical 
practice, risk factors that could be helpful in decision making to determine who needs 
treatment and who does not. I also questioned the increase in prevalence for pelvic girdle pain 
(PGP) in pregnancy, which has been reported during the last 20 years. Furthermore, I 
wondered whether any of my clinical tests actually could help me identify the tissue causing 
the pain and tell me something about prognosis.  
Before I started my work as a PhD student, I cooperated with researchers at the 
Norwegian Institute of Public Health, analyzing data from a population study including 
questions about PGP.80  The main result was that prevalence of PGP in pregnancy was 46% in 
this cross-sectional study. Work on this paper inspired me to enroll as a doctoral student, and 
to plan the cohort study together with my supervisors. 
Hence, this thesis is based on my persistent curiosity about pregnant women and pain 
in the pelvic area. I believe that by improving our understanding of risk factors for 
development of PGP we can provide a basis for new approaches to both the prevention and 
treatment of the condition. I assumed that in a prospective design not influenced by recall 
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bias, the prevalence of PGP in pregnancy would be lower than 46%.80 When introducing 
clinical examinations we would also acquire more information about pain locations, the tissue 
involved, and also the degree of affliction. It seemed important to find out if the clinical 
examination could provide information about the development of PGP during pregnancy and 
the risk for sustained problems after delivery. I thought that if we studied PGP in a cohort of 
pregnant women, it would also be possible to evaluate the effect of pregnancy itself on 
function and disability throughout pregnancy and in the postpartum period. 
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7 INTRODUCTION 
Pregnancy is supposed to be a happy period of life for women, associated with great 
expectations for the immediate future: the pregnancy period, the delivery, the child and 
motherhood. Among many women it seems to be an expectation that life continues more or 
less normally during pregnancy. Nevertheless, previous studies have shown that a large 
number of pregnant women report PGP.35;37;48;80 This condition impacts negatively on many 
of the daily activities, especially weight bearing activities such as walking and standing and 
several women have problems moving around.33;37;48;80 Hence, PGP affects both the activities 
of daily life and the quality of life during pregnancy.67 It has been an accepted understanding 
that PGP is most frequently experienced late in pregnancy, and that it disappears after 
delivery. However, studies have shown that several women do not recover as expected during 
the postpartum period, but instead develop chronic pain and report significantly lower health 
related quality of life than healthy women.88;89  It has also been reported that PGP is the major 
cause for sick-leave among pregnant Scandinavian women,32;92;93 and the costs to society may 
be great.  
A better understanding of the development of PGP as well as an identification of risk 
factors would be important for treatment and prevention purposes.   
 
7.1 Prevalence of PGP 
Several studies have examined the prevalence of PGP during and after pregnancy, and large 
variations in the estimates have been reported (ranging from 4 % to 90 % in pregnancy).114 
Furthermore, the condition has been looked upon almost as a “normal consequence of 
pregnancy that the woman must endure”.33 Recently published guidelines reveal that several 
studies suffer from methodological limitations such as lack of definitions of pain and 
diagnostic criteria for PGP. 106 Moreover, comparison of the results between studies may be 
problematic since the study designs and selection of the study population often differ. In some 
studies, women with PGP may also have been overrepresented due to the procedures. The 
European guideline group suggested that the prevalence of PGP in pregnancy is about  
20%,106 based on four studies,5;8;48;71 and that the evidence from this estimation is strong. 
However, this prevalence estimation can be questioned; since recently published studies have 
reported that the prevalence of PGP late in pregnancy may be more than 50%.35;61;67 
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It has been an understanding and also a persistent assumption that pregnant women in 
Scandinavia report PGP more frequently than women in other countries. Even though the 
majority of studies of PGP have been carried out in this area, there are studies from several 
other countries as well,9;59;63;81;99 indicating that PGP could be a more universal problem than 
a purely Scandinavian one.7  
Most of the women with PGP in pregnancy recover shortly after delivery, but studies 
over a longer follow-up period have reported that between 5 % - 7 % of the women suffer 
from sustained PGP for two years and longer after delivery.2;65 Again it is difficult to compare 
results across studies, since they differ in several methodological aspects.  
 
7.2 Affliction 
PGP has an impact on the pregnant women’s function and is exacerbated due to weight 
bearing activities (like walking and standing).74;106 In clinical examinations of 
musculoskeletal disorders in general, the assessment of function is an important factor for 
providing effective management of patients.111 Hence, it seems important also to study how, 
and to what degree, PGP afflicts pregnant women. Apart from a few recently published 
studies,35;67;80 previous studies have been more concerned with the prevalence of PGP than the 
consequences of having PGP. In clinical practice a large amount of information is collected in 
order to be able to provide patients with optimal treatment, to set relevant goals and also to 
evaluate the effect of treatment.111 It is now common to view health and health related quality 
of life no longer as dependent only on the individual, but rather as complex results of 
biological, psychological and social factors in accordance with the International Classification 
of Functioning, Disability and Health (ICF).112  
 When evaluating affliction from PGP it seems incomplete to only obtain data about 
presence and absence of PGP, the intensity of pain as well as disability is also important. 
Hence, graded scales are necessary. 
 
7.3 Potential causes of PGP 
The causes of PGP in pregnancy are not well understood, and both mechanical and hormonal 
factors are suggested.3;27;46;54;72 The pelvis can be regarded as a main bony platform, 
connected to the spine and legs, which have to be stabilized during weight bearing activities 
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and movement. Relaxation of the pelvic joints is seen as a normal physiological response to 
pregnancy. The relation between relaxation and pain is not established, although one 
empirical suggestion is that relaxation of the ligaments leads to instability of the pelvic joints 
(sacroiliac joints (SIJ) and pubic symphysis), which then again leads to pain. Hence the 
increased mobility in the SIJ has been understood as a cause of PGP.  
There have been discussions and disagreement over the years concerning the degree of 
mobility in the SIJ and the association between mobility and pain. The mobility of the SIJ is 
slight and according to the work by Sturesson and co-workers, no differences in mobility 
were found between symptomatic and asymptomatic SIJ when using roentgen stereo 
photogrammetric analysis.90 Furthermore, they concluded that the increased mobility could 
not be the cause of the pain. Later on, Damen and co-workers used Doppler imaging of 
vibrations in their studies, and examined the mobility in the SIJ.19 Their results showed that 
asymmetric mobility in the SIJ was associated with PGP. Nevertheless the relationship 
between mobility in the pelvic joints and PGP is still unclear. 
 
7.4 Pain distribution 
The associations between pain locations and the structures possibly responsible for the pain 
are not well documented or understood. Based on the understanding that relaxation of the SIJ 
might be the cause of PGP, efforts have been made to explore the pain referral patterns (pain 
distributions) from the SIJ.25;26 Different types of injections into the joints and adjacent areas 
in combination with clinical tests and procedures have been used to examine the correlation 
between pain location and clinical tests.49;51;52 The criticisms against the published pain 
referral patterns from the SIJ are founded on the contention that they identify pain coming 
from within the joints, rather than considering that pain might also come from extra-articular 
structures close to the joints. The latter might explain why the pain distribution described in 
the definition of PGP from the European Guideline group is broader than the referral map of 
SIJ pain presented in previous studies.25;26;106 Based on the results from several studies 
combining injections and clinical tests, Laslett and co-workers suggested that the symptoms 
and signs of PGP and the SIJ are concurrent and that the results from clinical tests are 
identical for the two conditions.49 Furthermore, that PGP and SIJ pain could represent the 
same entity when pain in the pubic symphysis is excluded from PGP. 
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7.5 Clinical examinations and tests 
The use of different criteria makes it difficult to compare diagnoses and classifications of PGP 
in both research and clinical work.5;48 Usually the clinical diagnosis is made on the basis of 
two sets of information: i) self reports of pain and functioning and ii) clinical findings. 
Information for example on pain location, pain-provoking actions, history of low back and 
pelvic girdle pain, limitations in daily activities and demographic variables are usually 
collected in clinical practice as well as by interviews or questionnaires in epidemiological 
studies. It has been an understanding that pain located to the area of the SIJ and/or pubic 
symphysis is characteristic symptoms for PGP.106 Difficulties in walking have been reported 
as a typical symptom in several studies,43;91 and have also been mentioned as diagnostic 
criteria.48  
The clinical examination of patients with musculoskeletal pain in general, focuses on 
identifying the underlying mechanisms of the pain (pathophysiology) and the functional 
status. This information is used as a guide to provide adequate treatment.16 Clinical tests are 
most often used to confirm a symptom (pain) or presence of a sign (for example instability).  
The underlying empirical premises are that the tests reveal information about involved 
structures and mechanisms and that specific signs and symptoms need specific therapeutic 
Figure 1 Front view of the pelvis. The 
right SIJ is shown without ligaments. 
Figure 2 Back view of the pelvis. The 
long dorsal sacroiliac ligament (LDL) is 
shown on the right side. 
The Coccyx The pubic symphysis 
The left 
hip joint 
The SIJ The SIJ 
The LDL 
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actions. Although pain may be referred, it is commonly assumed that identification of the 
structures or mechanisms involved may be a helpful method by which to identify more 
homogeneous subgroups. Clinical examinations include functional tests and pain provocation 
tests. The clinical examinations of women with PGP aim at obtaining further information on 
pain location, pain-inducing situations, (in)stability and mobility of joints, side differences in 
mobility or muscle activation and the ability of the neuromuscular system to stabilize the 
pelvic joints. A number of different tests are applied both in research and in clinical practice 
when examining women with PGP. The posterior pelvic pain provocation (P4) test and the 
functional Active Straight Leg Raise (ASLR) test are of particular interest due to their 
theoretical and empirical relevance for PGP.57;58;74 
 Previous studies have emphasized the importance of discriminating between pain from 
the lower back and pain from the pelvic area,35;42;44;75;91 and it has been suggested that the 
diagnosis of PGP can only be reached after exclusion of lumbar cause of pain, and functional 
disturbances must be reproduced by specific clinical tests.106  Several tests intend to meet 
these requirements. For example, the (passive) straight leg raise test, related to suspected 
nerve root pain and possible involvement of the intervertebral discus, are one test used for 
differential diagnostic purposes.100 The McKenzie system also has elements in their 
examination procedures that are assumed to identify possible discogenic pain.21 However, 
these procedures are often used in combination with pain provocation tests for the pelvic 
joints,35;51;115 tests that have shown variable degree of reliability.50;79;97 The extent to which a 
golden standard for validity exists may also be questioned.98 Furthermore, few of the actual 
tests have been examined for their ability to discriminate between PGP and LBP, but rather 
between no pain and PGP.  
In general, a clinical evaluation of low back pain should be sufficient to identify red 
flag conditions and to decide whether nerve root pain is present.100 Even though previous 
studies have reported that the presence of sciatica in pregnancy is uncommon,47;71 this could 
be important to keep in mind also when examining pregnant women.  
The evidence that supports the association between the different classifications of pain 
location and clinical tests as well as their association to disability in pregnant women is still 
lacking. Consequently, there is a need to study these associations further.  
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7.6 Risk factors for development of PGP 
Several possible risk factors for development of PGP in pregnancy have been examined, and a 
recent review reported a total of 15 possible risk factors for lumbopelvic pain (combination of 
LBP and PGP) in pregnancy.114 Strong evidence was reported for strenuous work, previous 
LBP, and previous PGP as risk factors. However, several of the included studies were cross-
sectional and used only bivariate statistical methods. Hence they are not methodologically 
sufficient to provide information on risk factors for development of PGP, but only on 
associations and correlations (table 1).  
The European guideline group concluded that the risk factors for development of PGP 
most probably are a history of LBP prior to pregnancy and previous trauma to the pelvis.106 
Furthermore, the group stated that contraceptive pills, time interval since last pregnancy, 
height, weight, smoking and most probably age were not risk factors. Again, these 
conclusions must be interpreted with caution because inappropriate statistics were used in 
some of the original studies (table 1).  
Over the past 15 years, firm evidence has been established for the importance of fear- 
avoidance beliefs and psychological distress as contributors to low back pain.15;102;110 Due to 
the similarities between LBP and PGP one may hypothesize that these factors are also 
important for the development of PGP. Furthermore, since PGP reportedly influences weight 
bearing activities, fear of increased pain due to activity may be an important risk factor. For LBP 
the effect of fear avoidance beliefs is seen even at very early stages of the clinical course,14;31 
suggesting that it may be important to investigate whether these factors are present in early 
pregnancy and represents risk for development of PGP. It has been suggested that low back 
disability is causally related more to fear avoidance than to pain or physical pathology,109 but 
similarly, this has not been examined for PGP. Grotle and co-workers compared the level of 
fear- avoidance beliefs and distress in acute and chronic LBP.31 The level of fear-avoidance 
beliefs and distress were lower in patients with acute LBP for the first time compared with 
patients with chronic LBP. Furthermore, fear-avoidance beliefs and distress were associated 
with disability in both acute and chronic LBP. According to the European Guideline group, 
the role of “yellow flags” has not been investigated among PGP patients, but, “based on the 
present limited knowledge, the impression is that yellow flags are less common among 
patients with PGP than with LBP”.106 One recently published study reported that in early 
pregnancy women with lumbopelvic pain reported higher levels of exaggerated negative 
thoughts and fear-avoidance beliefs than women without pain.66 To our knowledge, fear 
23 
 
avoidance and distress have not been examined as risk factor for either the development of 
PGP in pregnancy or for sustained PGP postpartum.  
Information from the patient’s history and the clinical examination form the basis for 
diagnosis and management strategies in clinical work with patients, but there has been little 
focus on responses to clinical tests as potential risk factors for development of PGP. 
Nevertheless, risk factors could be more useful in the clinical work if they were helpful in 
development of priority strategies for prevention and treatment. Hence, most of the suggested 
risk factors from previous studies would be of little help. 
24 
 
 
Table 1: Studies examining risk factors for developing PGP in pregnancy  
 
Author Design and 
statistical approach 
Outcomes Follow up – methods Results 
Mantle et al. (1977) 55 
 
n=180 
Cross-sectional 
Associations 
Backache Questionnaire in labor 
ward 
Age and parity were correlated with backache. 
No associations between back ache and height, weight, 
weight gain, baby’s weight 
Fast et al. (1987)24 
N=200  
Cross-sectional 
Retrospective 
LBP Interview 24-36 hours 
postpartum  
None of the variables (age, weight gain during pregnancy 
baby’s weight, parity) were associated with LBP 
Berg et al (1988) 8 
 
n=862 
Prospective 
Population based 
cohort 
Chi-square 
Associations  
LBP  
 
(SIJ- 
dysfunction) 
Questionnaire x 3 during 
pregnancy. Severe pain: 
examined* by orthopedic 
surgeon (n=72) 
Previous history of LBP, heavy work and smoking were 
associated with LBP.  
Parity, exercise habits and work satisfaction not associated 
with LBP 
Østgaard et al (1991) 71 
n=855 
 
Prospective 
Population based 
cohort 
Correlations 
 
Back pain 
complaints 
(High, low 
and 
sacroiliac) 
Questionnaire 7-9 times 
through pregnancy,  
 
Women with LBP: pain 
drawing and questionnaire 
Previous history of LBP, parity, young age, heavy 
workload, poor work satisfaction were correlated with 
increased prevalence of back pain 
No correlation between back pain and use of contraceptive 
pills or weight increase during pregnancy 
Orvieto et al (1994) 68 
 
n=449 
 
 
Cross-sectional 
 
Correlations, Chi-
square, t-tests, 
ANCOVA 
Low back 
pain 
Questionnaire; Women  
recruited for an antenatal 
ultrasound examination  
Low socioeconomic class, pre-pregnancy LBP, LBP 
during and between previous pregnancies were associated 
with risk for LBP 
Several ultrasonographic and obstetrical data, age, parity, 
gestational age, average maternal height, weight and BMI 
were not associated with increased risk for LBP  
Kristiansson et al  
(1996)45 
 
n=200 
Prospective 
Correlations 
 
Back pain 3 times during pregnancy 
and 12 weeks after. 
Clinical examination *  
More women with LBP had previous history of LBP, 
higher parity, larger weight increase during pregnancy 
No difference between no pain and LBP in smoking habits, 
age, BMI at first visit, time since last pregnancy 
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Larsen et al (1999) 48 
 
n=1600 (followed 
afflicted women, 
n=227) 
Prospective 
 
Logistic regression 
Symptom 
giving pelvic 
girdle 
relaxation 
Questionnaires, 
repeatedly: 227 of 1600 
fulfilled criteria of pelvic 
pain and were examined* 
by rheumatologist 
Risk factors: Previous history of LBP, pelvic pain in 
previous pregnancy, previous low abdominal pain, lack of 
exercise, bad working conditions 
No risk: Age, weight, carrying heavy loads at work, parity, 
smoking 
Mogren and Pohjanen 
(2005) 62  
 
 n=891 
Cross-sectional 
 
Logistic regression 
Low back and 
pelvic pain 
(LBPP) 
Questionnaire after 
delivery 
Increasing parity, history of hypermobility, BMI and 
amenorrhea were associated with LBBP  
Age at menarche, use of oral contraceptive were not 
associated with LBPP 
Albert et al (2006) 4 
 
n=2269 
 
Cross-sectional 
Retrospective  
 
Logistic regression 
 
 
PGP 
(subgroups 
based on pain 
locations)  
 
Questionnaire and clinical 
examination* in gestation 
week 33 
 
Previous history of LBP, previous trauma of back/pelvis, 
parity, higher level of stress, low job satisfaction were 
associated with development of PGP  
Age, marital status, full-time work, contraceptive pills, 
previous stillbirth, interval between pregnancies, hormonal 
induced pregnancy, urinary tract infection, less desire to 
become pregnant, BMI>30 were not associated with PGP 
*  The women were examined, but results of clinical examinations were not used as potential risk factor for PGP/LBP in the analyses 
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7.7 Risk factors for sustained PGP postpartum 
The European Guideline group concluded that the prevalence of PGP is about 20% in 
pregnancy and rapidly declines to about 7% three months postpartum.106 This leaves a rather 
high number of women suffering from PGP after delivery, and thus underscores the 
importance of identifying risk factors for non-recovery. One of the main reasons for 
identifying risk factors for development of chronic pain conditions is to be able to develop 
prevention strategies. PGP represents large costs for society; hence, a reduction in the 
number of women with chronic pain would be beneficial both for the women themselves 
and for the society as a whole. Studies of risk factors for sustained PGP postpartum have 
identified some of the same risk factors as for development of PGP during pregnancy.106;114 
History of back pain before pregnancy or during a previous pregnancy, high pain scores in 
pregnancy, reduced mobility in the hip joints and low social status are all identified as risk 
factors for sustained PGP after delivery (table 2). However, these studies are impaired by 
the use of different terminology and different definitions of pain locations, making it 
difficult to compare the results. Furthermore, methodological weaknesses and inappropriate 
statistics in several of the studies, render their conclusions on risk factors for sustained PGP 
postpartum insufficient. 
  It seems that little effort has been made to try to identify clinical risk factors for 
sustained PGP postpartum, and only a few studies have been found. Albert and co-workers 
divided PGP in pregnancy into sub-groups according to pain locations within the pelvic area.2 
Having pain in all three pelvic joints late in pregnancy was associated with a markedly worse 
prognosis after delivery than for other pain locations. Furthermore, a large number of positive 
clinical tests in late pregnancy gave high relative risk for persistent pain at two-year follow-up. 
Gutke and co-workers have identified combined LBP and PGP in pregnancy as a risk factor 
for sustained pain postpartum.36 Vøllestad and Stuge identified high scores on the ASLR 
test and low score on beliefs in improvement three months postpartum as risk factors for 
non-recovery one year after delivery.108 
 It is of importance to examine if there are clinical factors present in pregnancy that 
are associated with sustained PGP postpartum. This information could be used to develop 
strategies that can prevent further development of chronic conditions. This is important for 
the women themselves as well as for health personnel concerned about women’s health after 
pregnancy. Hence, it is a need for further studies that also include responses to clinical tests 
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as potential risk factors for sustained PGP postpartum. These should be prospective-design 
studies including appropriate statistics. 
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Table 2: Studies examining risk factors for sustained PGP postpartum 
 
Author Design & statistical 
approach 
Outcomes Follow up – methods Results 
Breen et al (1994) 10 
 
n=1042 
 
Prospective 
Pregnancy data collected 
retrospectively 
Multiple regression 
Postpartum 
back pain 
Interview after delivery 
and questionnaire 2 
months later 
Risk factors:  history of back pain, weight,  
younger age, greater weight 
No risk: Height, mode of delivery, neonatal 
birth weight and epidural anesthesia 
Ostgaard et al (1992) 70 
 
n=817 
Prospective 
Associations,  
comparison of means 
Postpartum 
back pain 
Questionnaire 12 months 
after delivery 
Presence of back pain before pregnancy or 
during pregnancy, physically heavy work 
and multi-pregnancy were factors that 
correlated to postpartum back pain 
Ostgaard et al (1996) 73 
 
n=164 
Prospective 
Correlations 
Back pain and 
posterior 
pelvic pain 
Questionnaire and 
examination. Treatment 
High pain intensity during pregnancy 
correlated with little regression of pain after 
delivery 
Brynhildsen et al 
(1998) 13 
 
n=146 
Cross-sectional 
Chi square, Mann 
Whitney, logistic 
regression 
LBP and SIJ 
pain 
Questionnaire 12 years 
after delivery 
Women with LBP/SIJ 
pain in pregnancy 
Previous (severe) LBP during pregnancy 
and heavy occupation increased the risk for 
current non-pregnant LBP 
Turgut et al (1998) 96 
n=88  
pregnant women, with 
back pain 
Prospective 
T-tests, comparison of 
means 
Back pain 
postpartum 
Questionnaire in 
pregnancy and 1, 3 and 6 
months after delivery 
Women with a previous history of back 
pain had a higher prevalence of back pain 6 
month postpartum, especially young multi-
pregnant women 
Albert et al (2001) 2   
 
n=341 
 
Prospective 
Correlations 
Bivariate analyses 
Pelvic girdle 
pain (PGP) 
From gestation week 33 
re-examined in intervals 
for 2 years after delivery. 
Followed women with 
PGP pregnancy 
Fewer women with combined symphysis 
and bilateral posterior pain recovered. High 
number of positive tests, reduced hip 
mobility, older age, non-education, 
unskilled work, high pain intensity were 
associated with pain two years postpartum 
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To and Wong (2003)95  
 
n=326 women, 
singleton pregnancies 
 
Prospective, observational 
cohort 
Associations  
Chi-square, t-tests, Mann-
Whitney 
Back pain (BP) Questionnaire in early 
postpartum (surveyed 
LBP in pregnancy 
retrospectively) and 24 
months after delivery 
Previous episodes of BP before or during 
pregnancy were associated with BP in 
pregnancy. Severe pain in early gestation 
and inability to reach pre-pregnancy weight 
were associated with BP 2 years postpartum  
Mogren (2006) 61 
  
n=639 women  
Follow-up women with 
LBPP 
T-tests and Chi-square, 
logistic regression 
LBPP (low 
back and 
pelvic pain) 
Questionnaire just after 
delivery, and 6 months 
postpartum 
BMI, hyper mobility, level and onset of 
pain during pregnancy were risk factors for 
persistent LBPP postpartum.  
Parity, gestational age, birth weight were 
not associated with persistent LBPP 
Rost et al (2006) 82 
 
n=430 pelvic pain 
patients  
Follow up study  
Logistic regression 
Pelvic pain Questionnaire to women 
who delivered less that 
42 months prior to 
follow-up (mean 18 
months) 
Pre-pregnancy back pain, severity of 
complaints, number of walking deficiencies 
as primary referral, duration of labor 
showed significant relation with symptoms 
in bivariate analyses. Only duration of labor 
in multivariable analysis 
Vollestad & Stuge* 
(2008) 108 
n=95, women with 
PGP 
Prospective 
Multivariable regression 
analyses 
PGP 
Pain and 
disability 
Examined when included 
into the study 
(postpartum) and one 
year after treatment  
ASLR test* and low score on beliefs in 
improvement were risk factors for non-
recovery 
Gutke et al (2008) 36 
 
n=308 
 
 
Prospective cohort study 
 
Multiple logistic 
regression methods  
No pain, LBP, 
PGP, 
combined 
LBP/PGP  
Examined in gestation 
week 12-18, sub grouped 
according to pain 
location and clinical 
examination**  
Women with combined LBP/PGP had 
lower degree of recovery.  
Low endurance of back flexors, older age, 
LBP/PGP in early pregnancy, work 
dissatisfaction were risk factors for 
persistent PGP or LBP/PGP postpartum 
*The only study identifying response to a clinical test as risk factor 
** Response of clinical tests were not examined as possible risk factors for sustained PGP, LBP PGP/LBP, however pain locations were used.
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8 AIMS  
The main objective of the research presented in this thesis was to explore factors related to 
pelvic girdle pain and disability during and after pregnancy and to estimate the prevalence of 
PGP at different time points. The specific research objectives of the three papers were: 
 
1. To examine the associations between pain locations, responses to the  posterior pelvic 
pain provocation (P4) test and the functional active straight leg raise (ASLR) test as 
well as their associations with disability in gestation week 30 (paper I).  
2. To identify socio-demographical, psychological and clinical risk factors in early 
pregnancy for disability and pain in gestation week 30 (paper II) 
3. To identify risk factors in late pregnancy among women with PGP, for sustained 
disability and pain 12 weeks postpartum (paper III) 
 
9 MATERIALS AND METHODS 
9.1 Designs 
The present thesis reports data from a large longitudinal study following a cohort of women 
from their first visit at the maternity care units (MCU), through their pregnancy period and up 
until one year postpartum. Data were collected at inclusion (mean gestation week 15), in 
gestation week 30 and 36, 6 and 12 weeks postpartum and one year postpartum. The present 
thesis includes three papers. In paper I a cross-sectional design was used analyzing data from 
gestation week 30. In paper II we used a prospective longitudinal design with one follow-up 
in pregnancy, analyzing data from inclusion and gestation week 30. In paper III we used a 
prospective longitudinal design with one follow-up postpartum, analyzing data from gestation 
week 30 and 12 weeks postpartum. 
Figure 3 and 4 show flow charts of the entire study and the participants studied in the 
present thesis.  
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Figure 3: Flow chart over the time points for data collection of the entire study, and for the data included in the present 
thesis and the three papers.  
* Data from gestation week 28 was used for selection of women for examination in gestation week 30. 
**Data from gestation week 36, 6 weeks, and 1 year postpartum were not used in the papers in the present thesis. 
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Figure 4: Flow chart showing the participants in the cohort study from inclusion to 
12 weeks postpartum 
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Prior to the data collection, we composed the questionnaires for the study and included 
standardized questionnaires on health, health status, health locus of control, distress, fear-
avoidance beliefs, and disability used in previous studies. In addition we included questions 
about socio-demographics, about pain and the locations of the pain. The contents of the 
questionnaires were discussed with experts on PGP, and tested out by letting 4 pregnant 
women fill them in, as a control for validity and feasibility. The questionnaires used at 
inclusion, in gestation week 30, and 12 weeks postpartum contained almost the same 
elements, expect for the socio-demographical variables (table 3).  
 The clinical examinations included six pain provocation tests for the pelvic joints as 
well as the functional active straight leg raise (ASLR) test. It also included Beighton score for 
hypermobility (only at inclusion), as well as general functional, mobility and stability tests. 
The clinical examinations in gestation week 30 and 12 weeks postpartum were identical, 
except for the examination of hypermobility (table 4).  
 
Table 3: Contents of the questionnaires 
 Inclusion Gestation week 30 12 weeks postpartum 
Socio-demographical data X   
Modified FABQ X X X 
SF-36* X X X 
NHP* X X X 
Health Locus of control scale* X   
HSCL-25 X X X 
DRI X X X 
Physical activity X X X 
Questions about PGP and LBP X X X 
Complaints X X X 
* Data not used in the papers of this thesis.  
FABQ, fear avoidance beliefs; SF-36, Short form - 36; NHP, Nottingham Health Profile; 
HSCL-25, Hopkins symptom check list; DRI, disability rating index; PGP, pelvic girdle pain; 
LBP, low back pain. 
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Table 4: Overview of the clinical tests included in the examinations 
 
 Inclusion Gestation 
week 30 
12 weeks 
postpartum 
Beighton score for hypermobility X   
Fingertip-to-floor distance* X X X 
Schober’s test* X X X 
Modified Trendelenburg’s test#* X X X 
ASLR test# X X X 
P4 test# X X X 
Patrick Faber test# X X X 
Compression test# X X X 
Distraction test X X X 
Palpation of LDL# X X X 
Palpation of pubic symphysis  X X X 
Joint play of SIJ#* X X X 
* data not used in the papers in this thesis 
# performed on both sides 
ASLR, active straight leg raise; P4, posterior pelvic pain provocation; LDL, long dorsal 
sacroiliac ligament; SIJ, sacroiliac joints 
  
Used as sum 
of pain 
provocation 
tests (0-8) in 
the analyses  
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9.2 Participants and study samples 
The Norwegian public health service offers all women free health service during pregnancy 
and most women visit special maternity care units (MCUs) for this purpose. We collaborated 
with four MCUs in the Oslo area; one was located in central Oslo (the capital city, about 
580 000 inhabitants) whereas the other three covered one entire community just outside Oslo 
(about 24 000 inhabitants). 
 All Norwegian-speaking women signing in at these four MCUs between January 2006 
and June 2007 were consecutively invited to participate by the personnel at the MCU. Women 
not expected to have a normal pregnancy (as determined by the midwives) as well as women 
presenting at high gestational age were excluded. Out of 385 eligible women, 326 gave their 
informed consent for participation after getting oral and written information about the study. 
At inclusion all women answered a comprehensive questionnaire and were clinically 
examined by one out of two physiotherapists with post-graduate education in manual therapy. 
The examinations were performed at the respective MCU or at Hans and Olaf Physiotherapy 
clinic, located in the center of Oslo. To reduce bias, the examiner was not given access to any 
questionnaire data.76 
The next examination of the women was carried out in gestation week 30. We 
examined women with symptoms from the low back or pelvic area, as well as women without 
PGP. The selection of women was based on a short questionnaire, including three questions 
about low back and pelvic pain, distributed by the midwives and answered by the women in 
gestation week 28. To be selected for a new examination in gestation week 30, the women 
had to report pain located in the pelvic area or low back area once a week or more, and the 
pain had to be provoked by sitting, standing or walking. Healthy women without these 
symptoms were also selected. This resulted in the exclusion of 31 women (9 %) who were not 
examined in gestation week 30, but questionnaire data were obtained and they continued in 
the cohort. Several of these women had minor symptoms from the area in question, but did 
not meet the entire set of criteria. This group ended up smaller than expected, because more 
women than expected had symptoms of PGP. In retrospect we found that examining all 
women at all times would have been possible. The handling of the selection was done by an 
external person, and the therapists carrying out the examinations were not given access to this 
information. Following this procedure, we called 290 of the 326 women for a new clinical 
examination in gestation week 30. Of these, 283 met and constituted the study sample in 
paper I.  
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Out of the 326 women in the cohort, 280 had been included before they reached 
gestation week 20 and were thus defined as being in early pregnancy. Nine of them had a 
miscarriage and three were drop-outs before gestation week 30. Since paper II aimed at 
identifying risk factors for development of disability and pain, the 268 remaining women 
constituted the study sample in paper II. 
In paper III we aimed at identifying risk factors for non-recovery 12 weeks postpartum 
among women with PGP in late pregnancy. Hence, we needed criteria for constituting this 
group, and we decided to use self-reported pain combined with a level of disability. The 283 
women who met for a new clinical examination in gestation week 30 were defined as afflicted 
if: 1) they reported to have PGP (yes, no) and/or had marked in the pelvic area on the pain 
drawing, and 2) they had a DRI score above the 25 percentile for the 283 women being 
examined in gestation week 30 (DRI>22). Both criteria were required, and resulted in 179 
women afflicted with PGP and these women constituted the study sample in paper III. 
Table 5 shows the characteristics of the total number of women in the cohort, the 
samples used for the different papers, as well as for the women that declined participation. 
There were only marginal differences between the groups. 
 
 
 
 
 
 
 
 
 
 
37 
 
Table 5: Characteristics of participants in the cohort and the different study samples used in the papers, and of those that declined participation  
 
  Whole cohort 
n=326 
Paper I 
 n=283 
Paper II 
 n=268 
Paper III 
n=179 
Non-participants, 
n=59 
  Mean 
(SD) 
n (%) Mean 
(SD) 
n (%) Mean 
(SD) 
n (%) Mean 
(SD) 
n (%) Mean 
(SD) 
n (%) 
Gestation age 
(weeks) 
 15 (5)  15 (5)  14 (3)  15 (4)  16 (5)  
Age (years)  31.5 (4.2)  31.3 (4.2)  31.3 (4.1)  31.3 (4.4)  30.7 (4.7)  
Weight (kg)  67 (11)  67 (11)  67 (11)  67 (11)  -  
BMI (kg/cm2)  23.4 (3.5)  23.4 (3.5)  23.3 (3.5)  23.6 (3.7)  -  
Education 
(years) 
 16 (2)  16 (3)  16 (3)  16 (3)  -  
Employed   303 (93)  240 (85)  228 (85)  164 (92)  54 (92) 
On sick leave at 
inclusion 
  62 (19)  54 (19)  49 (18)  43 (24)  - 
Smoker   15 (5)  12 (4)  11 (4)  9 (5)  - 
Parity 0  196 (60)  167 (59)  157 (59)  98 (55)  26 (44) 
 1  103 (32)  92 (33)  86 (32)  64 (36)  30 (51) 
 ≥2  27 (8)  24 (8)  25 (9)  17 (9)  3 (5) 
BMI, body mass index 
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9.3 Measurements of affliction 
In paper I we used disability as a response variable, assessed by the Disability Rating Index 
(DRI) in gestation week 30. In paper II we used two graded scales as response variables, 
DRI and pain intensity (worst evening pain) assessed in gestation week 30. In paper III we 
used the same two graded scales; DRI and pain intensity (worst evening pain), measured 12 
weeks postpartum, as response variables. In addition we also used a dichotomous response 
variable in paper III based on a combination of pain in the pelvic area and DRI. Salèn and 
co-workers reported that in a population of healthy persons with minor ailments the median 
value of DRI was 8.7 points (IQR 15.4).83 Based on this, a cut-off of ten was chosen as a 
reasonable distinction between recovered and non-recovered women 12 weeks postpartum.  
The women in the present cohort were defined as non-recovered if 1) self-reported PGP 
and/or markings in the pelvic area on the pain drawing were present and 2) DRI was above 
10.83 This variable was assumed to distinguish those with affliction to a certain level from 
the others. The use of response variables are shown in table 6 and described below.  
 
 
Table 6: Overview of the response variables used in the different papers 
 
 Paper I Paper II Paper III 
DRI, gestation week 30 X X  
Pain intensity (VAS), gestation week 30  X  
DRI, 12 weeks postpartum   X 
Pain intensity (VAS), 12 weeks postpartum   X 
Recovered (yes/no)*   X 
*Non-recovered was defined as pain in the pelvic area combined with DRI>10 points 
DRI, disability rating index; VAS, visual analogue scale. 
 
9.3.1 Disability (DRI) 
To our knowledge, none of the existing questionnaires for measuring disability have been 
made especially for PGP. Previous studies of PGP have used different disability 
questionnaires, most often designed for use on patients with LBP. The Oswestry Disability 
Index (ODI) is widely used in back pain populations,23 and it has also been used in studies 
of women with PGP.35;88;89;108 However, all the questions included in the ODI are associated 
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with pain, and we considered it difficult for the women to give meaningful information if 
pain was not present. The latter would be the case for several of the women in the cohort.   
 In order to allow assessment of disability in women with and without PGP, we chose 
to use the DRI in the present cohort study.83 DRI measures disability by assessing 
limitations in daily activities independent of pain. As for ODI, it was also primarily 
designed for patients with back pain. Although DRI has been less frequently used than the 
ODI, it has been used in studies of pregnant women before.45;67;88 We evaluated the items as 
suitable for pregnant women with PGP or LBP as well as for pregnant women without pain. 
DRI consists of 12 items scoring the ability to perform activities of daily living (dressing 
without help, outdoor walks, climbing stairs, sitting for a longer time, standing bent over a 
sink, carrying a bag, making a bed, running, doing light work, doing heavy work, lifting 
heavy objects, participating in exercise/sport). The items were scored on visual analogue 
scales (VAS) ranging from 0 – 100 mm, with end points “ability to perform activity without 
restriction” and “inability to perform the activity”. We calculated DRI as the mean of the 
twelve scales. Some of the criticism against using DRI in pregnancy is founded on the 
objection that it includes activities that pregnant women tend to stop doing (running for 
example); hence, a high score on DRI could be the result of pregnancy and not necessarily 
of PGP.45;66;67 By including women independent of the presence or absence of PGP, our 
intention was to measure the possible effect of pregnancy on function as well as the 
additional effect of PGP.  Furthermore, our clinical experience told us that women of today 
are increasingly likely to continue with their usual physical activities during pregnancy, and 
we expected that DRI could also be suitable to mirror this.  
 
9.3.2 Pain intensity 
It has recently been pointed out that pain is a symptom that is either present or absent, but 
when it is present, there may be a considerable variation in severity.18 Furthermore, pain is a 
usual experience of adult human life.39;40 Based on the assumption that there is a large 
variation in severity of pain, and since graded scales have been recommended,18  we decided 
to use a measure of pain intensity. Since PGP increases with activity,48;74 we evaluated the 
intensity of evening pain to be the most relevant measure for the degree of pain. It was 
measured by the response to the following question: “How intense is your worst PGP before 
going to bed?”   The response was measured by a 0-100 mm visual analogue scale (VAS) 
and the end points were “no pain” and “unbearable pain”.  
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9.4 Explanatory variables - potential risk factors 
The selection of explanatory variables were based on the results from previous studies as 
well as on the hypothesis that the response to clinical tests could be risk factors for  
1) development of PGP in pregnancy  
2) sustained PGP postpartum  
We measured the explanatory variables in early pregnancy (paper II) and in gestation week 
30 (papers I and III) 
 
9.4.1 Socio-demographical data 
The following socio-demographical data were included in the questionnaire used at 
inclusion:  
age (years) 
marital status (single, married/cohabitant)  
parity (0, 1, ≥2 children)  
gestation week at inclusion 
height (cm) 
weight (kg) 
education (≤12 years of school attendance, ≤4 or >4 years at university) 
use of contraceptive pills last year before pregnancy (yes, no) 
smoking status (yes, no) 
physical activity before pregnancy (none, < 2, 2 - 4, > 4 hours per week) 
 
Pre-pregnancy body mass index (BMI, weight/height2) was calculated from self-reported 
height and weight, and was categorized as normal weight and overweight (<25 kg/m2, ≥25 
kg/m2).113 
We identified the women’s working situation from the question: “How would you 
describe your work situation?” With four response alternatives: 1) Most of the time seated; 
2) I have to walk a lot; 3) I walk and lift objects; 4) Heavy work. We categorized working 
condition as mostly seated work (response alternative 1) and heavy work (response 
alternatives 2-4). Furthermore, we also identified full-time work (yes, no). 
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9.4.2 Psychological data 
The Hopkins Symptom Check List (HSCL-25) was used to measure distress (self-reported 
symptoms of anxiety, depression and somatization).78 Twenty-five symptoms were recorded 
on a scale from 1 (not bothered) to 4 (extremely bothered). We calculated the average value 
to obtain the HSCL-25 score and used a cut-off value of 1.75 as established for women by 
Sandanger and co-workers (1998).84 The cut-off value reflected non-specific distress, rather 
than a psychiatric diagnosis.  
Fear avoidance beliefs were measured by the modified Fear Avoidance Beliefs 
Questionnaire (mFABQ).53 This includes four of the items from the part concerning activity 
in the original Fear avoidance beliefs questionnaire.53;110 We chose the modified version 
because it could also be answered by women without pain. In line with the work by Linton 
and co-workers,53 we included the following introductory text in the questionnaire: “Some 
women will be afflicted by pain in the back and pelvic area during pregnancy. For research 
purposes, we would like to know if you believe that there is a relationship between such 
afflictions and activities. Please circle the number on the scale that best corresponds to your 
belief for each of the following statements.” The scale ranged from 0 (total disagreement) to 
6 (total agreement) and the total score on mFABQ ranged from 0-24. 
 
9.4.3 Pain history and pain locations 
Pre-pregnancy history of LBP was identified from the question: “Have you suffered from 
LBP before pregnancy (yes, no)?”  
We calculated the number of pain sites from the questions asking the women if they 
had pain (yes, no) in the neck, shoulder and arms, between the shoulder blades, in the knees. 
The sum score (0-4) was used as a categorical variable in the analyses.  
Pain located in the pelvic area and the low back area, were used as separate 
variables, determined from a pain drawing filled in by the women before each clinical 
examination. After the examination, the women were asked to point out the pain sites on 
their body and, if necessary, the examiner corrected the pain drawing to reflect the areas 
pointed out. 
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The pain locations in the pelvic area were 
subsequently coded: no PGP, pain in 
symphysis only, only posterior pain (uni- or 
bilateral), combined symphysis pain and 
unilateral posterior pain, and combined 
symphysis pain and bilateral posterior pain 
(figure 5 and 6). We coded pain above the 
level of L5/S1 to be LBP (figure 7).  
To avoid bias, the examiner was blinded to 
the pain drawings until after the examination 
was performed. 
 
 
 
 
 
  
Figure 6: Illustrations of areas required for 
classification as combined symphysis pain 
and unilateral posterior pelvic pain* 
Figure 7: Illustrations of areas required for 
classification as LBP*, irrespective of 
radiating pain to the leg(s) 
 
*The pain drawings are used with the kind permission from Professor Elisabeth Ljunggren, 
Physiotherapy Research group, Department of Public Health and Primary Care, University 
of Bergen, Norway 
Figure 5: Illustrations of areas required for 
classification as combined symphysis pain 
and bilateral posterior pelvic pain* 
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9.4.5 Clinical examination 
The clinical examinations included the functional active straight leg raise (ASLR) test, the 
posterior pelvic pain provocation (P4) test and the following pain provocation tests: the 
distraction test, the compression test, the Patrick Faber test, the palpation test of the pubic 
symphysis and the palpation test of the long dorsal sacroiliac ligament (LDL). When 
assessing the pain provocation tests, we recorded if a familiar pain was provoked. All tests 
are commonly used, and moderate to excellent inter-rater reliability has been 
reported.50;56;74;79;97;98 
The ASLR test (figure 8):56  was 
performed with the women in a supine 
position with straight legs and feet 
about 20 cm apart. The women lifted 
each leg separately about 20 cm above 
the bench and was asked to score the 
difficulty on a six-point scale from 0 
(not difficult to lift) to 5 (impossible to 
lift). The scores on both sides were 
added and the ASLR test ranged from 
0-10. We used the ASLR as a  
 
Figure 8: The ASLR test 
categorical variable (sum score: 0, >0 in paper I and III, sum score <4, ≥4 in paper II).  
 
The P4 test (figure 9):74 was performed 
with the women in a supine position. 
The hip on the tested side was flexed to 
90◦. The examiner stabilized the 
contralateral side of the pelvis and 
applied a graded force on the flexed 
knee into the pelvis along the 
longitudinal axis of femur. Adduction 
of the hip was avoided. It was recorded 
whether a familiar pain was felt in the 
posterior part of the pelvis on the 
provoked side (yes, no).  
 
Figure 9: The P4 test 
20 cm 
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The scores were added and used as a categorical variable (sum score: 0, 1, 2). According to 
Østgaard and co-workers, the anatomical origin of the provoked pain is unknown and several 
anatomical structures may be involved and responsible for the pain reaction.74  
 
 
The distraction test (figure 10):52 the 
women were examined in supine 
position. The examiner applied cross-
armed pressure to the anterior superior 
iliac spines directed laterally. This 
procedure was assumed to stretch the 
anterior sacroiliac joint ligaments and 
give compression in the dorsal part of 
the sacroiliac joints. It was recorded 
whether pain was felt in the posterior 
or anterior part of the pelvis. The pain 
response was recorded (yes, no). 
 
 
 
Figure 10: The distraction test 
 
The compression test (figure 11):79 
the women were examined in side-
lying position, knees and hips slightly 
flexed. Pressure was applied vertically 
into the pelvis when the examiner 
leaned her chest against the 
uppermost iliac crest. The test is 
assumed to stretch the posterior 
sacroiliac joint ligaments and 
compress the anterior part of the 
sacroiliac joints. Both sides were  
 
Figure 11: The compression test 
 
tested and scored separately. The pain response was recorded (yes, no).  
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The Patrick-Faber test (figure 12):12;86 the 
women were examined in supine position. 
The examiner led the ipsilateral leg into 
flexion, abduction and external rotation so 
that the heel rested on the opposite 
kneecap. The examiner stabilized the 
contralateral side of the pelvis to ensure 
that the lower back stayed in a neutral 
position. The ipsilateral knee was lowered 
against the bench and the examiner applied 
a light overpressure to the subject’s knee. It 
was assumed that both the anterior 
sacroiliac ligament and the hip joint were 
stressed. Both sides were tested and scored 
separately. The pain response was recorded 
(yes, no).  
 
 
 
Figure 12: The Patrick-Faber test 
Palpation of the pubic symphysis (figure 
13):1 the women were examined in supine 
position. The examiner applied gentle 
pressure to the pubic symphysis with her 
hand (flat fingers). If the pressure caused 
pain that persisted more than five seconds 
after removal of the hand, it was recorded 
as pain (yes, no).  
 
 
 
 
 
 
 
Figure 13: Palpation of the pubic symphysis 
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Palpation of the long dorsal sacroiliac 
ligament,  LDL (figure 14):107 the women 
were examined in side-lying position and 
the examiner palpated the LDL at the 
uppermost side, caudal of the posterior-
superior iliac spine. The test was positive if 
the palpation provoked a familiar pain and 
was recorded (yes, no). Both sides were 
examined and scored separately.  
 
 
 
 
 
Figure 14: Palpation of the LDL 
 
In paper I we used the responses to the ASLR test and the P4 test from the examination at 
inclusion. In paper II we used responses to all the clinical tests presented above, performed 
at inclusion. In paper III we used the responses to all the tests presented above, performed in 
gestation week 30. For paper II and III we added all positive responses to the above 
described pain provocation tests, apart from the P4 test, ranging from 0 (all negative) to 8 
(all positive). We used this sum score as a continuous variable in the analyses for paper II, 
and as a categorical variable with four levels in the analyses (0-1, 2-3, 4-5 and 6-8 positive 
tests) for paper III. Based on the P4 test’s specific relevance for PGP reported in previous 
studies,34;74 we decided to use the P4 as a single response and not as part of the sum score of 
positive pain provocation tests. ASLR test was also used as a single response (table 7). 
 The Beighton score99 was used as a measure for joint hypermobility. It consists of 9 
tests: hyperextension of the knees (yes, no), hyperextension (>10▫) of the elbows (yes, no), 
passive apposition of the thumbs to the flexor aspect of the forearm with straight elbow 
(yes, no), passive hyperextension of the 5th metacarpophalangeal joints ≥ 90▫ (yes, no) , 
forward flexion of the trunk, with knees straight, so that the palms of the hands rest easily 
on the floor (yes, no). We measured all angles with a goniometer.  A sum score (0-9) was 
made of the results of all the tests and hypermobility was defined when the sum score was 
four or higher.99;101 
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Table 7: Overview of explanatory variables used in the different papers  
  Paper I Paper II Paper III 
Socio-demographics  Age  X X X 
 Marital status  X X X 
 Parity  X X X 
 Height  X X X 
 Weight  X X X 
 Pre-pregnancy BMI X X X 
 Education  X X X 
 Smoking status  X X X 
 Pre- pregnancy physical activity   X X 
 Working condition   X X 
 Full time work   X  
 Gestation week at inclusion  X  
 Use of contraceptive pills year before 
pregnancy 
  
X 
 
X 
Psychological 
variables 
 
mFABQ 
  
X 
 
X 
 HSCL-25  X X 
Pain history and 
pain locations 
 
History of pre pregnancy LBP  
  
X 
 
X 
 Pain locations (pain drawings) X X X 
 Number of pain sites (0-4)  X X 
Clinical examination P4 test X X X 
 ASLR test X X X 
 Sum of pain provocation tests (0-8)  X X 
 Beighton score for hypermobility 
(≥4) 
 X  
Sum of pain provocation tests included the distraction and compression tests, Patrick Faber 
test, palpation of the pubic symphysis and LDL (sum 0-8). Pain locations were pain in the 
low back area and/or the pelvic area (symphysis pain only, posterior pain only, combined 
symphysis pain and unilateral posterior pain, combined symphysis and bilateral posterior 
pain). Number of pain sites included pain in: the neck, shoulder and arms, between the 
shoulder blades, and the knees (sum score 0-4). BMI, body mass index; mFABQ, modified 
fear avoidance beliefs questionnaire; HSCL-25, Hopkins symptom check list; P4, posterior 
pelvic pain provocation; ASLR, active straight leg raise. 
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9.5 Ethics 
The Regional Committee for Medical Research Ethics and the Norwegian Social Science 
Data Services gave formal approval of the study. All participants received written and oral 
information about the study. The women signed an informed consent before they were 
included in the study. 
This cohort study was an observational study, and we did not offer any treatment for 
the women with PGP. If the women asked for advice concerning pain, activities, and 
treatment we answered their questions. Concerning further questions on treatment, we 
followed the usual procedures at the MCUs and left it to the midwives to refer women to 
physical therapy clinics in the local neighborhood.  
 
9.6 Sample size and power estimates 
We estimated power in several ways due to the different analyses used in the three papers in 
this thesis. The estimate of sample size for the study was primarily based on the expected 
prevalence of PGP. We calculated the sample size (n) from the following equation: 
n=1.962p(1-p)/a2 
where “p” was the estimated prevalence (given as a fraction) and “a” was the chosen 
significance level. After reviewing the literature, we found that using a prevalence of PGP 
of about 20 % in late pregnancy was reasonable. This was also in accordance with the later 
published estimation of prevalence from the European Guideline group.104-106 Hence, we 
used p=0.20 and a=0.05 when calculating power. This resulted in n=246. However we 
needed to include more than 246 pregnant women in the cohort because the use of different 
subsets of the study sample might be necessary in the different analyses. Hence, we 
included a total of 326 pregnant women in the cohort. 
 Continuous variables were the main responses in the studies in this thesis and were 
also used in the power calculations for the correlation and regression analyses. The level of 
significance was set at 5 % (two-sided) and the power at 80 %. Assuming a correlation of 
medium size, 0.3, in the population, a sample size of 85 is required for assessing 
significance of a correlation coefficient in the sample.17 In a multiple regression analysis 
with five independent variables, the required sample size is 91 to detect a medium effect 
size of 0.15 (R2/(1-R2)).17 If we increased the number of independent variables to 8, the 
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required sample size is 107,17 thus the power should be sufficient since the study samples 
was 283, 268 and 179 women in papers I, II and III respectively. 
For the logistic regression analyses, the “rule of 10” says that the sample size is large 
enough if the size of the least frequent outcome group is greater than 10 times the number of 
variables in the model. 38 
 
9.7 Statistical analyses 
Several types of statistical analyses were used depending on the research questions and the 
variables used. Details regarding analyses are presented below. We used a 5 % level of 
significance in all papers. Statistical analyses were conducted using the statistical software 
program SPSS (version 15 for paper I and version 16 for papers II and III). 
 
9.7.1 Paper I 
Chi-square statistics were used to explore the strength of associations between the results of 
the clinical tests and the different pain locations. A one-way between-groups analysis of 
variance was conducted to explore the association between the pain locations and DRI. Due 
to the large number of comparisons involved, the Bonferroni post hoc adjustment was used 
to reduce the risk for Type 1 errors.6 Multiple linear regressions were used to explore the 
relationship between DRI (response variable) and the P4 test, the ASLR test and pain 
locations (explanatory variables). Interaction effects between the variables were tested, and 
the residuals were examined to check model assumptions.  
  
9.7.2 Paper II 
Multiple linear regression analyses were used to study the associations between potential 
risk factors measured in early pregnancy and DRI or pain intensity (worst evening pain) in 
gestation week 30. Associations between the explanatory variables and each of the response 
variables as well as between the explanatory variables were studied by Pearson correlation 
coefficients. The explanatory variables showing a significant relationship with the response 
variable or found important in previous studies were entered into a multiple linear 
regression model. The best subsets of explanatory variables were selected through exclusion 
of the variables with the smallest contribution to the model (the largest p-values). Two 
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adjusted models were presented for each of the response variables, without (model 1) and 
with (model 2) adjustment for DRI or pain intensity at inclusion in early pregnancy. Model 
2 was also included to examine the risk factors for the change in DRI or pain intensity from 
early to late pregnancy. The residuals were examined to check model assumptions. 
Interaction effects between the variables in the models were also tested.  
 
9.7.3 Paper III 
Multiple linear regression analyses were used to study the associations between potential 
risk factors measured in pregnancy and DRI or pain intensity (worst evening pain) measured 
12 weeks postpartum. Associations between the explanatory variables and each of the 
response variables as well as between the explanatory variables were studied by Spearman 
rank correlation coefficients.   
Explanatory variables significantly associated with the response variable or found 
important in previous studies were entered into a multiple linear regression model. The best 
subsets of explanatory variables were selected through exclusion of the variables with the 
smallest contribution to the model (the largest p-values). The residuals were examined to 
check model assumptions. Interaction effects were tested, but real interactions may go 
undetected since this test may lack power. 41  
Since a large number of the women reported low pain intensity and low DRI, 12 
weeks postpartum, we also repeated the multiple linear regression analyses after 
transformation (natural logarithms) of both pain intensity and DRI.  
In order to estimate the odds ratios for sustained PGP, we categorized the women as 
recovered or non-recovered 12 weeks postpartum based on a combination of pain and 
disability. Women were defined as non-recovered if self-reported PGP and/or markings in 
the pelvic area on the pain drawing were present and if the DRI was above ten points.83 A 
logistic regression model was used to study the associations between non-recovery and the 
same explanatory variables as used in the multiple linear regression analyses. We also used 
an alternative definition of non-recovery based on the definition described above, but in 
addition the pain intensity should be above ten on the VAS. The results from the logistic 
regression model were similar applying the two response variables.  
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10 MAIN RESULTS  
The results are described in detail in each of the papers, hence only a summary of the main 
results is given here.  
 
10.1 Prevalence of self-reported PGP 
The prevalence of self-reported PGP was high at all time points in this study (table 8). 
Within the entire cohort, 35 % of the women reported PGP at inclusion. At gestation week 
30 the prevalence had increased to 62 % followed by a decline to 31 % 12 weeks 
postpartum. At all three times this was based on the answer on a single question: “Do you 
have pain in the pelvic area?” 
 
10.2 Disability at gestation week 30 (paper I) 
In the cross-sectional study in late pregnancy (gestation week 30) we explored associations 
between pain locations, responses to clinical tests and disability. Self-reported pain locations 
were established from pain drawings, in two different ways; distinguishing between PGP 
and LBP as well as distinguishing between different pain locations in the pelvic area 
(symphysis pain only, posterior pain only, combined symphysis pain and unilateral posterior 
pain, combined symphysis pain and bilateral posterior pain). Disability was measured by the 
Disability Rating Index (DRI).  
 Large variations in DRI were constantly seen within each of the subgroups based on 
pain locations, and all subgroups had women reporting DRI below 10 and above 50 points.  
DRI was significantly associated with pain locations (p<0.001). Women with combined 
pain in the symphysis and bilateral posterior pain scored significantly higher on DRI 
compared with all other pain locations (p<0.001). PGP was more strongly associated with 
disability than was LBP. No difference in DRI was found between women reporting PGP 
and women reporting combined PGP and LBP. These results indicate that PGP has a 
significant impact on disability in pregnancy and that having LBP in addition does not 
increase the disability. 
Women with bilateral positive posterior pelvic pain provocation (P4) test scored 
significantly higher on DRI than women with unilateral positive P4 and bilateral negative 
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P4 (p<0.001). Furthermore a statistical higher DRI was found in women with active straight 
leg raise (ASLR) test score >0 compared with ASLR=0 (p<0.001).  
The multivariable linear regression analyses showed that pain locations in the pelvic 
area, responses to P4 and ASLR tests, contributed independently and statistically to the 
variation in DRI (R2=0.32,  p<0.001) (table 8).  
 
 
Table 8: Final multiple linear regression model for the associations between the response 
variable DRI at gestation week 30 and the explanatory variables: pain locations in the pelvic 
area, P4 and ASLR. The model contributed to 32 % of the variability in DRI. 
 
 Crude estimates Adjusted estimates3 
 β1 (95 % CI2) p-value β1 (95 % CI2) p-value 
Pain locations     
No PGP Reference <0.001 Reference <0.001 
Symphysis pain only 6.3 (-2.4, 15.1)  4.0 (-4.1, 12.1)  
Posterior pain only 12.1 (6.9, 17.2)  6.8 (1.6, 12.1)  
Combined symphysis pain and 
unilateral posterior pain 
 
14.7 (6.5, 22.8) 
  
9.7 (1.8, 17.6) 
 
Combined symphysis pain and 
bilateral posterior pain 
 
26.5 (20.1, 32.8) 
  
18.0 (11.3, 24.7) 
 
P4     
Negative Reference <0.001 Reference <0.001 
One-sided positive  2.4 (-3.5, 8.4)  -3.2 (-9.0, 2.4)  
Bilateral positive  16.4 (11.9, 21.0)  6.7 (1.8, 11.6)  
ASLR test     
score = 0 Reference <0.001 Reference <0.001 
score > 0 15.4 (11.1, 19.7)  10.9 (6.7, 14.9)  
1 Estimated regression coefficients, 2 CI, confidence interval, 3 adjusted for the other 
variables in the table; DRI, disability rating index; PGP, pelvic girdle pain; P4, posterior 
pelvic pain provocation test; ASLR, active straight leg raise test 
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10.3 Risk factors for disability and pain at gestation week 30 
(paper II) 
Paper II is a longitudinal observational study, following women from early to late 
pregnancy for the purpose of identifying risk factors for disability and pain in gestation 
week 30. Disability was measured by DRI and pain intensity (worst evening pain) by VAS, 
self-reported pain locations in the pelvic area, were established from pain drawings. The 
clinical examinations included pain provocation tests for PGP as well as the functional 
ASLR test. Response to the clinical tests, pain locations within the pelvic area (symphysis 
pain only, posterior pain only and combined symphysis pain and posterior pelvic pain) and 
previously identified risk factors for PGP were included in the analysis. 
 Self-reported pain locations in the pelvic area, responses to the P4 test, and sum of 
positive pain provocation tests in early pregnancy were identified as risk factors for 
disability and pain intensity in gestation week 30 in a multivariable regression model 
(p≤0.03) (table 9). In the model with pain intensity as response variable, the adjusted 
estimate for bilateral positive P4 test was 15.2 (95 % CI: 5.8, 24.6), thus this CI indicates 
that the P4 test is of significance even though p=0.07. In addition, distress was a risk factor 
for disability (p=0.006) but not for pain intensity.  
 To explore the change in DRI from early pregnancy until gestation week 30, we 
adjusted for DRI in early pregnancy in the model. This resulted in an increase in the R2 from 
0.26 to 0.37 and the sum of positive pain provocation tests and HSCL-25 were no longer 
significant (p=0.26 and p=0.49, respectively). To explore the change in pain intensity from 
early pregnancy until gestation week 30 we adjusted for pain intensity in early pregnancy in 
the model. This resulted in an increase in the R2 from 0.29 to 0.33 and the sum of positive 
pain provocation tests in early pregnancy was no longer significant (p=0.23). Further details 
are shown in table 4 and 5 in paper II. 
 Fear avoidance beliefs, a score on the ASLR test of four and above, and number of 
pain sites in other parts of the body in early pregnancy were not significantly associated 
with either DRI or pain intensity in gestation week 30. 
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Table 9: Final multiple linear regression models showing the associations between disability or pain intensity (worst evening pain)  in gestation 
week 30 and risk factors measured in early pregnancy (n=268) 
 
 DRI Pain intensity 
  
Crude estimates 
 
Adjusted estimates3 
 
Crude estimates 
 
Adjusted estimates3 
  
β1 (95 % CI2) 
 
p-value 
 
β1 (95 % CI2) 
 
p-value 
 
β1 (95 % CI2) 
 
p-value 
 
β1 (95 % CI2) 
 
p-value 
Pain locations 
No pain 
 
Reference 
 
<0.001 
 
Reference 
 
0.007 
 
Reference 
 
<0.001 
 
Reference 
 
<0.001 
Symphysis pain only 17.7 (6.8, 28.6)  14.0 (3.7, 24.1)  44.2 (27.7, 60.6)  40.4 (24.4, 56.5)  
Posterior pain only 10.7 (6.2, 15.3)  4.8 (-0.2, 9.6)  23.5 (16.6, 30.3)  15.3 (7.8, 22.8)  
Combined 
symphysis pain and 
posterior pain 
 
24.5 (15.6, 33.5) 
  
11.8 (2.6, 21.0) 
  
40.5 (26.9, 54.0) 
  
26.0 (11.6, 40.4) 
 
P4 test 
Negative 
 
Reference 
 
<0.001 
 
Reference 
 
<0.001 
 
Reference 
 
<0.001 
 
Reference 
 
0.07 
Unilateral positive 8.0 (2.6, 13.5)  2.2 (-3.4, 7.9)  16.5 (7.7, 25.2)  5.8 (-3.1, 14.8)  
Bilateral positive 19.8 (14.3, 25.2)  12.0 (6.0, 18.0)  28.6 (19.9, 37.3)  15.2 (5.8, 24.6)  
Sum of positive 
pain provocation 
tests  
 
5.3 (3.9, 6.7) 
 
<0.001 
 
1.7 (0.3, 3.0) 
 
0.02 
 
6.3 (4.5, 37.3) 
 
<0.001 
 
2.3 (0.3, 4.4) 
 
0.03 
HSCL-25 
<1.75 
 
Reference 
 
<0.001 
 
Reference 
 
0.006 
 
- 
 
- 
 
- 
 
- 
≥1.75 14.0 (7.6, 20.3)  8.2 (2.3, 14.0)      
1 Estimated regression coefficients, 2 CI, confidence interval, 3 adjusted for the other variables in the table. DRI, Disability Rating Index; P4 test, 
posterior pelvic pain provocation test; HSCL-25, Hopkins Symptom Check List  
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10.4 Risk factors for disability and pain 12 weeks postpartum 
(paper III) 
Paper III is a longitudinal observational study following women afflicted by PGP from late 
pregnancy (gestation week 30) until 12 weeks postpartum for the purpose of identifying risk 
factors for sustained disability and pain 12 weeks postpartum. Disability was measured by 
DRI and pain intensity by VAS 12 weeks postpartum. We used the same clinical tests as in 
paper II but the data were taken from the tests performed in gestation week 30. Clinical 
variables (from gestation week 30) together with previously identified risk factors were 
included in the analysis. 
 Based on multivariable linear regression analyses, sum of positive pain provocation 
tests was a risk factor for both disability and pain intensity 12 weeks postpartum 
(0.03≤p≤0.04) (table 10). Pre-pregnancy LBP was a risk factor for DRI 12 weeks postpartum 
(p=0.03) and number of pain sites in other parts of the body was a risk factor for pain 
intensity (p=0.007). Pre-pregnancy BMI was also associated with both disability and pain 
intensity and the response to the ASLR test was associated with disability, though none of 
them significantly. 
In order to estimate odds ratios (OR) for non-recovery from PGP postpartum, we 
defined women as recovered or non-recovered based on pain locations in the pelvic area and 
disability. Women were non-recovered if self-reported PGP and/or markings in the pelvic 
area on the pain drawing were present and if the DRI was above 10. We performed a logistic 
regression analysis including the same risk factors as described for the linear regression 
analyses (table 11). The number of pain sites in other parts of the body and sum of positive 
pain provocation tests were significantly identified as risk factors. The odds increased with 
increased number of pain sites and OR was 4.4 (95 % CI (1.3, 14.6)) for women with 3-4 pain 
sites as compared to women with no pain sites in the adjusted analyses. Moreover, OR was 
3.5 (95 % CI (1.2, 10.3)) for women with 6-8 positive provocation tests as compared to 
women with 0-1 positive test. Pre-pregnancy BMI was also associated with non-recovery, 
though not significantly. 
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Table 10: Final multiple linear regression analyses showing associations between DRI or pain intensity (worst evening pain) 12 weeks 
postpartum and risk factors measured in gestation week 30 (n=179).  
 
 DRI Pain intensity 
 Crude estimates Adjusted estimates3 
 
Crude estimates 
 
Adjusted estimates3 
 
 β1 (95% CI2) p-value β1 (95% CI2) p-value β1 (95% CI2) p-value β1 (95% CI2) p-value 
Pre-pregnancy BMI         
<25 kg/m2 Reference 0.03 Reference 0.07 Reference 0.02 Reference 0.05 
≥25 kg/m2 5.6 (0.5, 10.6)  4.6 (-0.3, 9.5)  8.8 (1.5, 15.1)  5.7 (-0.3, 11.8)  
Pre-pregnancy LBP         
No Reference 0.04 Reference 0.03 - - - - 
Yes 5.0 (0.3, 9.8)  5.0 (0.5, 9.5)  -  -  
Sum of positive pain 
provocation tests 
        
0-1 pos tests Reference <0.001 Reference 0.03 Reference 0.006 Reference 0.04 
2-3 pos tests 3.4 (-1.7, 10.5)  1.0 (-6.2, 8.3)  5.7 (-4.1, 15.5)  2.3 (-7.4, 11.9)  
4-5 pos tests -1.7 (-4.8, 8.1)  -0.4 (-6.9, 6.2)  5.4 (-3.5, 14.3)  1.3 (-7.4, 10.1)  
6-8 pos tests 12.0 (5.7, 18.3)  7.7 (1.1, 14.3)  15.1 (6.4, 23.8)  11.2 (2.4, 19.8)  
ASLR test         
Score = 0 Reference 0.005 Reference 0.05 - - - - 
Score > 0 7.6 (2.3, 12.9)  5.4 (-0.1, 10.9)  -  -  
Number of pain sites         
0 - - - - Reference 0.03 Reference 0.007 
1 -  -  3.9 (-3.5, 11.4)  1.5 (-5.9, 9.0)  
2 -  -  9.9 (0.4, 19.3)  8.8 (-0.5, 18.2)  
3-4 -  -  21.5 (10.7, 32.3)  18.7 (7.9, 29.6)  
1 Estimated regression coefficients, 2 CI, confidence interval, 3 Adjusted for the other variables in the table. DRI, Disability Rating Index; BMI, 
body mass index; LBP, low back pain, ASLR, active straight leg raise 
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Table 11: Multiple logistic regression analyses showing crude and adjusted odds ratios with 
95% confidence intervals for non-recovery 12 weeks postpartum due to pre-pregnancy BMI, 
number of pain sites and sum of positive pain provocation tests measured in gestation week 
30. 
 
 Crude estimates Adjusted estimates3 
 β1 (95% CI2) p-value β1 (95% CI2) p-value 
Pre-pregnancy BMI     
<25 kg/m2 1.0  1.0  
≥25 kg/m2 2.2 (1.1, 4.4) 0.03 2.1 (1.0, 4.5) 0.05 
Number of pain sites     
0 1.0  1.0  
1 2.8 (1.2, 6.2) 0.01 2.3 (1.0, 5.5) 0.05 
2 2.3 (0.8, 6.4) 0.1 2.0 (0.7, 5.7) 0.21 
3-4 5.2 (1.7, 15.9) 0.004 4.4 (1.3, 14.6) 0.02 
Sum of positive pain 
provocation tests 
    
0-1 pos tests 1.0  1.0  
2-3 pos tests 1.7 (0.5, 5.5) 0.40 1.2 (0.3, 4.0) 0.82 
4-5 pos tests 1.5 (0.5, 4.4) 0.51 1.0 (0.3, 3.3) 0.94 
6-8 pos tests 5.0 (1.8, 14.0) 0.002 3.5 (1.2, 10.3) 0.02 
1 Estimated regression coefficients, 2 CI, confidence interval, 3 Adjusted for the other 
variables in the table; BMI, body mass index 
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11 GENERAL DISCUSSION 
The central aspects in each of the studies have been discussed in the respective papers. The 
discussion part of this thesis we will concentrate on some important methodological aspects 
as well as on the discussion of some main issues across the studies.  
 
11.1 Discussion of methodological aspects  
11.1.1 Participants and study samples 
This thesis is based on a cohort study of women recruited consecutively among Norwegian 
speaking pregnant women at four MCUs in the Oslo area. Women not expected to have a 
normal pregnancy (as determined by the midwives) and women in late gestational age were 
excluded, but no further selections were made in the recruitment procedure. Out of 385 
eligible women, 326 women aged 18 – 45 years participated (mean 31.4 years). According 
to Statistics Norway, the average age for women giving birth in Norway was 30.3 years for 
the period 2006 – 2008, and women giving birth in Oslo were a bit older than in the rest of 
the country.85 Twelve percent of all Norwegian women who had live births in 2008 were 
single.85 These numbers suggest that the participants in the cohort may be representative for 
pregnant women living in urban parts of Norway. Only 15 % (59/385) declined participation 
in the study, and 8 % (27/326) of the participants dropped out during the study period (13 of 
these, 50 %, withdrew due to a miscarriage). We evaluated the characteristics of the women 
in the cohort to be similar to the women who declined participation (table 5 page 37). 
Furthermore the differences between the groups of women selected and used in the analyses 
in the different studies are also slight. The similarities of the samples and the non-
participants suggest that our samples were comparable.  
Our intention was to include pregnant women early in pregnancy, before PGP was 
present. Based on information from the MCUs we expected most women to register 
between gestation week 12 and 18. Although some women registered earlier and others later 
than we expected; we decided not to change our protocol. Instead, the women included later 
than gestation week 20 were excluded from the analyses in paper II (risk factors for 
development of disability and pain). Since we were concerned about the effect of the broad 
gestation age interval at inclusion, we also controlled for the effect of gestation week at 
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inclusion in the analyses. As described in the results in paper II, we found that gestation 
week at inclusion had no significant effects. 
 
11.1.2 Design 
The results presented in this thesis are based upon self-reported (subjective) data and 
clinical (objective) data collected two times in pregnancy (at inclusion in early pregnancy 
and in gestation week 30) and one time after delivery (12 weeks postpartum).  A prospective 
design (used in paper II and III) is needed to be able to examine risk factors for development 
of a condition (PGP). A cross-sectional design (as used in paper I) has some limitations 
concerning the opportunity to draw conclusions.20 Since all data are collected at the same 
time, it is not possible to conclude whether exposure or response came first, and no 
conclusions about cause-effect relationships can be drawn. However, this design was 
satisfactory in paper I since the purpose was to study associations among different factors 
measured at the same time.    
 Multivariable regression analyses were used to explore associations between the 
potential risk factors and the response variables and to estimate the explanatory power of the 
different risk factors. Using multivariable analyses, as opposed to bivariate analyses, makes 
it possible to identify and control for effects from other variables, i.e. confounding effects 
and interactions.6  When we compare our results with previous studies, we see that most of 
the previously identified risk factors were not significantly associated with the response 
variables when using multivariable models (except pre-pregnancy LBP and pre-pregnancy 
BMI). This may be because the clinical variables absorb the effect of other variables. Hence, 
some of the explanation for the different results compared with previous studies could be 
the use of a different design, clinical explanatory variables, different response variables 
(discussed further also in chapter 11.1.3), and statistical methods.  
 Blinding procedures are recommended and important in research to avoid bias from 
awareness.76 The physiotherapists performing the examinations in the present cohort study 
were not given access to any information about the women until after the examination. The 
women were examined independent of the presence or absence of PGP. This design is 
different from previous studies which often have examined only the women presenting with 
pain.8;33;48 Furthermore, no predefined classifications were used in the clinical examinations 
in this thesis. This means that the tests were performed and the responses recorded without 
including any clinical rationale, and without any attempts to establish a diagnosis. The 
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examinations were done for research purposes and these procedures increase the quality of 
the data gathered from the tests. Hence the examination-procedure differs from ordinary 
clinical practice. Nevertheless, this procedure provided opportunities to use the responses to 
clinical tests both as single data as well as different independent clusters or sum scores in 
the analyses.  
We selected women for examination in gestation week 30 based on a simple 
questionnaire concerning pain in the pelvic and/or low back area in gestation week 28. A 
small group of women (9 %) were not selected for further clinical examinations. However, 
all women in the cohort were included in the prevalence estimates based on self-reports at 
each time point, but in the analyses using data from clinical examination at gestation week 
30 this group of women could not be included since they were examined only once (at 
inclusion). The close similarity in the entire sample of 326 participants, and the sample used 
for the different analyses and papers (table 5, page 37) suggest that the selection has not 
caused a large bias. 
A large fraction of the women without PGP, but also several with PGP scored low 
on both disability (DRI) and pain intensity 12 weeks post partum; hence the data were 
skewed. We controlled for this effect in two ways (paper III): by repeating the multiple 
linear regression analyses with pain intensity ln transformed and DRI ln transformed as well 
as by using logistic regression analyses and a constructed response variable for non-
recovery based on both pain and DRI. The results were similar for all approaches and this 
indicates that the results are robust and trustworthy. 
The sum of positive pain provocation tests was identified as a risk factor for 
disability and pain in both gestation week 30 and 12 weeks postpartum. The variable was 
used differently in the analyses at the two times; in the analyses in paper II, it was used as a 
continuous variable, and in paper III it was used as a categorical variable. The results in 
paper III showed that the largest effect was when 6-8 tests were positive. In retrospect, 
therefore we see that this variable probably should have been used as categorical variable 
also in paper II.  
The ASLR test was used with different cut-off values in the papers in this thesis. 
Initially we intended to use a cut-off in the ASLR score that distinguished between women 
with strong affliction and those without or lesser affliction. Hence we evaluated the 
previously proposed cut-off value of one to be too low.56 In both paper I and II we therefore 
decided to use a cut-off of four and above for the afflicted group, as also used as an 
inclusion criterion in the RCT by Stuge and co-workers.88 In the revision process on paper I 
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we were asked by the reviewers to change this cut-off to one, in accordance with the 
original work by Mens and co-workers.56 This was done and did not change the initial 
results of paper I. The revision process for paper II was ongoing in parallel with paper I, and 
the cut-off was not changed in paper II. In retrospect, we see that this probably could have 
been done for the consistency of the papers, although a change would implicate a less strict 
criterion for the afflicted group. Additional analyses have been performed to enable a 
discussion of the implications of using the different cut-off values.  The results are presented 
and discussed in chapter 11.2.4.  
 
11.1.3 PGP and measures of affliction 
Several studies have used self-reported PGP (yes/no) as an outcome 
measure.45;62;67;68;80 Two main elements are included in the definition of PGP from the 
European Guideline group; the location of pain and the reduced endurance in conjunction 
with weight bearing activities.106 Hence both pain and function are evaluated as important 
for the condition. These elements are also assessed and evaluated in the clinical examination 
of PGP patients. In previous studies PGP has been regarded as both a normal discomfort 
during pregnancy,24;68 and a severe and disabling problem.13 Hence the view on affliction 
from PGP seems to vary. Since we believe that affliction cannot be described based on a 
yes/no question, we included two measures for the degree of affliction in the current papers; 
disability (DRI) and pain intensity (worst evening pain, measured by VAS). Both variables 
are continuous and are intended to provide more graded information about affliction than 
merely presence or absence of PGP. Although the use of graded scales has been 
recommended,18 it has not been used in studies examining PGP in pregnancy before.  
The response variables used in the present studies are all subjective, however in 
different ways. A yes/no response to the question about presence of PGP is highly 
dependent on the women’s own evaluation of the pain as well as the location of pain and is 
probably also culturally influenced. As for the presence or absence of PGP, also the graded 
scales are self-reported and thus subjective. Pain intensity (measured by VAS) is a 
subjective phenomenon quantifying the pain. DRI surveys the difficulties in performing 
specific activities; hence it is the degree of difficulty that is assessed. The nature of pain 
makes objective measurement of intensity impossible,11 but it is possible that disability 
could have been measured more directly. To our knowledge, no such specific disability 
measurement for use in pregnant women exists. The only functional test specifically aimed 
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at PGP is the ASLR test which has been found to discriminate between PGP patients and 
healthy subjects.56 Furthermore difficulties in performing the ASLR has presently shown to 
be associated with increased mobility in the pelvic joints as well as disease severity in PGP 
patients.57;58 Strong associations between ASLR and DRI were found in the cross-sectional 
study in paper I. This finding suggests that the impairments assessed by ASLR are closely 
related to limitations in activities as reflected by DRI when measured at the same time.29  
Pain is often characterized by the assessment of location, intensity, and temporal 
aspects.11 These assessments are used in both research and clinical practice. The women 
with PGP in the present cohort study reported large individual variations of pain intensity. 
This is in accordance with a recently published review on differences in pain sensitivity by 
Nielsen and co-workers,64  saying that “even though some conditions may be more painful 
than others, the variation between individuals with the same condition is far greater than the 
difference in painfulness across conditions”. Patients may experience pain differently, and 
even with the same injury some may not report any pain at all.103 It still seems important to 
measure the women’s own perception of pain. 
Several instruments have been developed and used to assess pain intensity.11 The 
visual analogue scale (VAS), as used in the present thesis, is often used for assessing worst, 
least, or average pain over the past 24 hours or during the past week. The measure of pain 
intensity can probably be seen as even more subjective and less calibrated than DRI. 
Furthermore, disability is said to be one of the most substantial consequences of pain.103 The 
latter can explain the strong correlation between pain intensity and DRI seen in both 
gestation week 30 and 12 weeks postpartum.  
 We have argued for the use of graded scales in this thesis, since PGP can be present 
with little affliction. Yet, we have also used dichotomous variables and estimated the odds-
ratios for sustained PGP 12 weeks postpartum among women afflicted from PGP in 
pregnancy (paper III). We used two dichotomous variables, based on presence of PGP and a 
degree of disability to:  
1. define women afflicted from PGP in gestation week 30  
2. define non-recovered women 12 weeks postpartum.  
We used the graded scales to standardize afflicted women in late pregnancy and non-
recovered women postpartum, respectively. Since our data showed that pregnancy 
influenced DRI, we used a cut-off value on disability above the effect of pregnancy itself to 
estimate a main effect of PGP in gestation week 30. Furthermore, women without affliction 
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postpartum should report disability comparable with healthy women. In the study from 
Salèn and co-workers,83 almost none of the healthy individuals scored above ten (median 
DRI was 0.8, IQR 4.7 for healthy individuals with no disability, and median DRI was 8.7, 
IQR 15.4 for healthy individuals with minor ailments). The described procedure, used in 
paper III, differs from what has been done before, since most previous studies have used 
presence of PGP as a criterion.2;10;13;61;70;73;82;95;96 It could be discussed to what extent our 
definition of non-recovered women is adequate for identification of those with sustained 
PGP. This can only be tested by analyses in later follow-ups. However, the mean DRI and 
pain intensity of this group were 30 (IQR 25) and 34 (IQR 47) respectively and indicate that 
they had a relatively high affliction compared with healthy women and other patient 
groups.83 
The need for measurement tools specially designed for pregnancy-related PGP has 
been discussed and the European Guideline group concluded that: “Future studies should 
therefore address the challenge of developing suitable outcome measures to assess the 
functional status for PGP.”106 However, the use of established measurement tools seems 
important in order to be able to compare results between different studies and also between 
different patient groups and healthy individuals. The DRI as a measure of disability, has 
been used in different studies, and comparison could be made between this cohort and a 
Swedish cohort of pregnant women,67 as well as with healthy women of the same age and 
patient groups.83  
 
11.1.4 Clinical examinations and tests 
Different studies have used different tests in their assessment, mostly for establishing the 
diagnosis of PGP, and have not examined the responses to the tests as potential risk factors. 
The ideal clinical test has high levels of reliability, sensitivity and specificity. A common 
internal validity concern is connected to the clinimetric properties of the clinical tests. The 
reliability and validity for tests used for examining pain in the pelvic area have shown large 
variations.50;77;79;86;97;98 We selected mainly pain provocation tests for this thesis. A recently 
published study has also shown that reliability and validity for single pain provocation tests 
as well as composite of tests were good when injections procedures in the SIJ and adjacent 
structures were used.52 As mentioned before, the relationship between SIJ and PGP is 
unclear and the validity of the tests used for PGP can still be questioned. In a previous study 
we evaluated four of the actual pain provocation tests (distraction test, compression test, P4 
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and Patrick-Faber), and found the reliability to be moderate to good.79 However, when it 
comes to validity, there are more uncertainties concerning structures responsive for the pain, 
and thus the lack of a diagnostic reference standard is obvious and could be problematic.   
 Even though there are uncertainties concerning the clinimetric properties of the 
clinical tests, we believe that we have selected relevant tests and optimized the performance 
and interpretation of the results. Furthermore, the identification of responses to clinical tests 
as risk factors for PGP has not been studied previously.  
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11.2 Discussion of results 
11.2.1 Prevalence of PGP  
Prior to the data collection for the present study, a population based retrospective 
questionnaire study was carried out.80 This included 1,817 women from two communities 
just outside Oslo, recruited in 1998-99, and the prevalence of PGP was 46%. It was our 
hypothesis that this high prevalence could be partly due to recall bias and that lower values 
would be found in a prospective design. However, the self-reported prevalence in the 
present cohort study was 35% and 62% in early and late pregnancy, respectively. Hence, the 
prevalence in the retrospective study was probably not an overestimation caused by the 
study design. On the opposite, our data seems to indicate even higher prevalence. Several 
factors may have contributed to this fact. Like in several other studies, the estimates of the 
prevalence are based on self-reported presence or absence of the condition.22;45;55;62;67;68 For 
the prevalence estimates we used the answer from a simple question in the present thesis: 
“Do you have pain in the pelvic area?” (Yes/no). Hence, the response depends on the 
women’s individual understanding of the concept and the influence of the cultural 
environment. The high prevalence could be due to the fact that the social and medical 
acceptances of PGP have increased in Norway during the last 15 – 20 years, and that the 
focus on PGP has increased.22;43 The prevalence is, however, in accordance with recently 
published studies in other countries.35;62;63;67 The large prevalence numbers could also 
indicate that the threshold for reporting PGP was low. It could also be a risk for over 
reporting PGP due to the focus of being participants in a study. We have tried to limit the 
over-reporting by reducing the focus on PGP both in the questionnaires and in the 
information (oral and written) given to the women.  
 
11.2.2 Disability in pregnancy – a normal or pathological response? 
In clinical practice, it is a common belief that in pregnant women with PGP the physical 
disability during pregnancy is caused by PGP. However, it seems reasonable that pregnancy 
in itself might also cause disability, since pregnancy induces great bodily changes in the 
women. The increase in body weight and change of body posture may impact on physical 
function. A comparison of DRI scores for women with and without PGP in this study could 
give a picture of the pregnancy effect on disability (figure 15). The DRI values of the 
women without PGP 12 weeks postpartum (the only non-pregnant data-set) are low and 
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exhibit a rather narrow range. These scores are comparable with DRI from healthy women 
of approximately the same age,83 and this suggests that most of the women are not afflicted 
by disability 12 weeks postpartum. Comparing these values with the DRI scores at inclusion 
for women without PGP can possibly show the pregnancy effect on disability, already 
present in early pregnancy. The increase in disability in women with PGP at inclusion, 
compared with women without PGP, is the additive effect from PGP in early pregnancy, 
also shown previously.67 Furthermore, an increase in disability is seen from inclusion until 
gestation week 30 in women with and without PGP. However, the women with PGP have 
more disability than women without PGP.  
The median DRI score in gestation week 30 among women with PGP in the present 
cohort was 44 (IQR 26.7), and thus comparable (but with somewhat larger variation) with 
scores from patients with other musculoskeletal disorders classified with mild-to-moderate 
disability. In the study from Salèn and co-workers a combined group of patients with neck, 
shoulder, or LBP (all classified with mild-to-moderate disability) scored 39 (IQR 19.5) 
points on DRI.83  
There is a possibility that the multiple linear regression models could have identified 
risk factors within a small range of the continuous response variables. The response variable 
used in the logistic regression model distinguished between women with negligible 
disability and women with a certain level of disability. Since the clinical risk factors were 
identified also in the logistic regression model this strengthens our results.   
In the present cohort the range of DRI is higher among women with PGP at all three 
times compared with women without pain. This finding indicates a wide variation in 
affliction when PGP is present. Mean DRI 12 weeks postpartum among women with PGP 
was low (20) in this cohort, indicating low functional impairment postpartum even when 
pain is present. Corresponding value of DRI among the women included in the RCT three 
months postpartum from Stuge and co-workers was 54.87 Only about 7 % of the women in 
the present cohort sought treatment postpartum, and this might explain the low DRI 
compared with the women included in the RCT. 
The mean pain intensity due to PGP 12 weeks postpartum was also low, and lower 
than reported at inclusion. This shows that women with PGP in this cohort have more pain 
in early pregnancy than 12 weeks postpartum.   
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When studying the single items in DRI (figure 16), one sees almost the same patterns as for 
the summarized DRI scores (figure 15). Women with PGP tend to score higher at all three 
times compared with women without PGP, which means they report more functional 
impairment than women without PGP. The exception is in the item “dressing without help” 
where a “floor effect” is seen, implying that this is not a problem for the women in this 
cohort. 
For the items “running”, “doing heavy work”, “lifting heavy objects” and 
“participating in exercise/sports” we see that at 12 weeks postpartum the women with PGP 
score higher on these items and the range was wider in comparison with the rest of the 
items. During pregnancy there is also a higher effect from both pregnancy and PGP on these 
items compared with the other items. This confirms that several pregnant women have 
difficulties with strenuous activities, but this is common for women both with and without 
PGP. These findings do not disqualify the use of DRI on pregnant women.    
 Figure 15: Box-plot showing the effect of pregnancy on DRI at inclusion, gestation week 
30 and 12 weeks postpartum. Data is given for the whole cohort (n=326) split according 
to presence or absence of PGP at the three times. Median, quartiles and range are 
shown. Circles show outliers (>1.5 IQR above the 75th percentile) Asterisks show extreme 
values (>3 IQR above the 75th percentile) 
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Pain intensity UT???? 
Figure 16: Box-plot of the single items in DRI at the three time points. Data is given for the 
whole cohort (n=326) split according to presence or absence of PGP. Median, quartiles 
and range are shown. Circles show outliers (>1.5 IQR above the 75th percentile) Asterisks 
show extreme values (>3 IQR above the 75th percentile) 
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11.2.3 Risk factors for development of PGP and sustained PGP postpartum 
(papers II-III)  
The risk factors for development of disability and pain intensity in late pregnancy and the 
risk factors for sustained disability and pain intensity 12 weeks postpartum are shown in 
table 12.  
 
Table 12: Risk factors for development and prolongation of PGP during and after pregnancy 
 Response variables 
 Disability Pain intensity 
Risk factors for 
development of PGP 
during pregnancy  
 
Pain locations within the pelvic 
area 
 
 
Pain locations within the 
pelvic area 
 
(Paper II) P4 test 
Sum of positive pain provocation 
tests 
Distress (HSCL) 
P4 test 
Sum of positive pain 
provocation tests 
Risk factors for 
sustained PGP 
postpartum  
 
(Paper III) 
 
Sum of positive pain provocation 
tests 
 
ASLR test* 
 
Pre-pregnancy LBP 
 
Sum of positive pain 
provocation tests 
 
Number of pain sites in other 
parts of the body 
  
Pre-pregnancy BMI* 
 
Pre-pregnancy BMI* 
*associations but not significant 
PGP, pelvic girdle pain; P4, posterior pelvic pain provocation; HSCL, Hopkins symptom 
check list; ASLR, active straight leg raise; LBP, low back pain; BMI, body mass index. 
 
 
To our knowledge, this study is the first prospective cohort study to identify clinical 
risk factors (pain locations within the pelvic area, responses to clinical tests) while 
controlling for socio-demographical and psychological factors. Most of the factors identified 
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as risk factors in previous studies (e.g. age, parity, and strenuous work conditions) were not 
associated with the response variables when using multivariable analyses. This may indicate 
that the clinical factors are stronger and absorb the effect of most of the socio-
demographical and psychological variables. Furthermore, previous studies have often 
recorded risk factors retrospectively in late pregnancy after the onset of symptoms of 
PGP.4;62 These factors could be biased by the presence of pain.60 The use of a prospective 
design and recording of possible risk factors early in pregnancy (paper II) before onset of 
symptoms or before the symptoms were defined as a problem, reduced this bias.   
 The effect estimates are large for the clinical risk factors, and in both gestation week 
30 and also 12 weeks postpartum the estimates for pain intensity seems to be higher than for 
DRI (table 9, page 54 and table 10, page 56). For instance our data (gestation week 30) 
shows that pain intensity in late pregnancy is 40.4 points higher (95 % CI: 24.4, 56.6) when 
pain was present in the symphysis only, compared with having no pain in early pregnancy 
and adjusted for positive response to the P4 test and the sum of positive pain provocation 
tests. Even though the confidence intervals are large, the associations between clinical risk 
factors and effects of PGP seem to be strong. These results could be of importance in 
clinical practice, since the same information is collected and used for decision making and 
selection of treatment modalities.   
Interestingly, we identified different risk factors for disability and pain in gestation 
week 30 than 12 weeks postpartum (table 12). However, the sum of positive pain 
provocation tests is consistent for both response variables at both times (gestation week 30 
and 12 weeks postpartum).  
Pain locations in the pelvic area reported in early pregnancy were risk factors for 
both disability and pain in gestation week 30 but pain locations in gestation week 30 were 
not risk factors for any of the responses 12 weeks postpartum. This is surprising, and also in 
contrast to what has been reported earlier.2;36 Albert and co-workers reported that combined 
pain in symphysis and bilateral posterior pain in late pregnancy was a risk factor for non-
recovery 2 years postpartum.2 However, only bivariate associations were examined. Gutke 
and co-workers reported that combined PGP/LBP in pregnancy was a risk factor for pain 3 
months postpartum.36 It could be that the responses to the clinical tests identified as risk 
factors in the present studies absorbed some of the effect from pain locations. The results 
from paper I, where the P4 and ASLR tests were associated with pain locations in gestation 
week 30 could support this assumption.  
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Most of the clinical risk factors can be seen as condition specific, while pre-
pregnancy LBP, distress and pre-pregnancy BMI are more general and also reported in 
relation to both PGP and LBP before.10;28;61;70;82;94-96 
Surprisingly none of the psychological factors, except for distress, were identified as 
risk factors for either disability or pain in late pregnancy or postpartum. This is in contrast to 
studies where psychological factors and emotional distress have been shown as important 
factors for non-recovery of acute LBP.28;30;31 Fear avoidance beliefs were not identified as 
risk factor for either disability or pain intensity in the present study. This finding is in 
contrast to what has previously been reported for acute LBP and could support the need for 
differentiating between LBP and PGP. 35;42;75 In a recent study, Olsson and co-workers 
found that women with pain in early pregnancy reported significantly higher levels of fear 
avoidance beliefs than women without pain.66 However, the study was cross-sectional and 
did not examine risk factors for PGP. The present study reports recovered /non-recovered 
three months postpartum. It is possible that a longer follow-up period may reveal effects of 
psychological factors.  
The number of pain sites in other parts of the body in gestation week 30 was a risk 
factor for pain intensity 12 weeks postpartum and pain intensity was almost 19 mm higher 
(95 % CI: 7.9, 29.6) when 3-4 pain sites in other parts of the body were present compared 
with having no pain sites and adjusted for the sum of positive pain provocation tests and 
pre-pregnancy BMI (table 10, page 56).  This is in accordance with a prospective study on 
LBP showing that widespread pain was a risk factor for persisting LBP,94 even though the 
variables are not completely comparable.  
11.2.4 Measurement scales used in different ways 
The response to the ASLR test was associated with both disability and pain in the cross-
sectional study (paper I), but it was not a risk factor for development of PGP (paper II). As 
explained in chapter 11.1.2, different cut-off values were used in the paper in this thesis. We 
repeated the analyses in paper II with a cut-off value of one (instead of four) for the ASLR 
score, and the results show that ASLR with the low cut off has a significant effect for both 
DRI and pain intensity as response variables (Tab 13). The effects remain for the risk 
factors identified in paper II. The only exception is for the sum of positive pain provocation 
tests which is no longer a significant risk factor for pain intensity.  Hence, when used with a 
cut-off on one, the response to ASLR test in early pregnancy is identified as a risk factor for 
both disability and pain intensity in gestation week 30. When the ASLR test is used with a 
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distinction between women with a strong affliction and those with less or no affliction, as 
shown in paper II, the ASLR was not a risk factor for either disability or pain intensity 
(0.53≤p≤0.71).  One possible explanation for the difference in results might be due to a 
smaller number of women with a positive ASLR test when using the higher cut off value 
(n=28 vs. n=110), and thus a lower power. Alternatively, there might be fundamental 
differences between the phenomena studied when using different score levels of the ASLR.  
 We also repeated the analyses in paper II with sum of positive pain provocation tests 
as a categorical variable (0-1, 2-3, 4-5 and 6-8 positive tests) as done in paper III. This 
analysis resulted in a significant effect of only 4-5 positive tests. Since there was only 12 
women with 6-8 positive tests, the power of the test for this group was low and possibly of 
importance for the non-significant result.  
 The differences of results when using the scales in different ways show that there is a 
need for more research on these clinical measures. 
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Table 13 Adjusted estimates for DRI and Pain intensity with two different levels of cut-off on the score of the ASLR test. 
 DRI Pain intensity 
 Adjusted estimates3  Adjusted estimates3  
  
With ASLR score on 
four and above * 
 
With ASLR score on one 
and above  
 
With ASLR score on 
four and above*  
 
With ASLR score on one and 
above   
 β1 (95 % CI2) p-value β1 (95 % CI2) p-value β1 (95 % CI2) p-value β1 (95 % CI2) p-value 
Pain locations 
No pain 
 
Reference 
 
0.007 
 
Reference 
 
0.01 
 
Reference 
 
<0.001 
 
Reference 
 
<0.001 
Symphysis pain only 14.0 (3.7, 24.1)  12.4 (2.1, 22.6)  40.4 (24.4, 56.5)  37.2 (21.1, 53.3)  
Posterior pain only 4.8 (-0.2, 9.6)  4.4 (-0.4, 9.2)  15.3 (7.8, 22.8)  14.7 (7.2, 22.1)  
Combined 
symphysis pain and 
posterior pain 
 
11.8 (2.6, 21.0) 
  
11.7 (2.6, 20.8) 
  
26.0 (11.6, 40.4) 
  
25.1 (10.9, 39.4) 
 
P4 test 
Negative 
 
Reference 
 
<0.001 
 
Reference 
 
0.001 
 
Reference 
 
0.07 
 
Reference 
 
0.02 
Unilateral positive 2.2 (-3.4, 7.9)  2.4 (-3.3, 8.0)  5.8 (-3.1, 14.8)  6.1 (-2.8, 15.0)  
Bilateral positive 12.0 (6.0, 18.0)  11.2 (5.1, 17.2)  15.2 (5.8, 24.6)  13.6 (4.2, 23.0)  
Sum of positive 
pain provocation 
tests  
 
1.7 (0.3, 3.0) 
 
0.02 
 
1.4 (0.04, 2.7) 
 
0.04 
 
2.3 (0.3, 4.4) 
 
0.03 
 
1.7 (-0.4, 3.8) 
 
0.1 
HSCL-25   <1.75  Reference 0.006 Reference 0.04 - - - - 
                    ≥1.75            8.2 (2.3, 14.0)  6.4 (0.4, 12.5)  - - - - 
ASLR          0 -  Reference 0.04 - - Reference 0.01 
                   >0 -  4.7 (0.1, 9.3)  - - 8.7 (1.8, 15.6)  
* As presented in paper II 
1 Estimated regression coefficients, 2 CI, confidence interval, 3 Adjusted for the other variables in the table. DRI, Disability Rating Index; P4, 
posterior pain provocation; HSCL, Hopkins symptom check list; ASLR, active straight leg raise.   
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12 CONCLUSIONS  
The following conclusions can be drawn from the work in this thesis:  
• There is a high prevalence of PGP during and after pregnancy 
• Disability is increased in late pregnancy but a large variation is seen among both the 
women with and without PGP 
• PGP has an additive effect on disability in pregnancy 
• In late pregnancy there is an association between pain locations in the pelvic area, 
responses to the posterior pelvic pain provocation test, P4, and the functional ASLR 
tests and disability (DRI) 
• Pain locations in the pelvic area and responses to the P4 test measured in early 
pregnancy were risk factors for increased disability (DRI) and pain intensity reported 
in gestation week 30 (in addition, distress was a risk factor for DRI) 
• Sum of positive pain provocation tests (measured in gestation week 30) and pre-
pregnancy LBP were risk factors for sustained disability (DRI) 12 weeks postpartum 
• Sum of positive pain provocation tests and number of pain sites in other parts of the 
body (measured in gestation week 30) were risk factors for sustained pain intensity 
12 weeks postpartum 
 
The high prevalence of PGP during and after pregnancy indicates that there is a need for 
attention by health care providers. The large variation in disability at all times regardless of 
presence or absence of PGP shows that pregnancy itself has an impact on function. 
Furthermore the results confirm the clinical experience that women with PGP report large 
variation in affliction. The identification of clinical risk factors for PGP is a novel finding 
and probably of importance for further development of treatment and prevention strategies. 
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13 CLINICAL IMPLICATIONS AND FURTHER 
RESEARCH 
The novel finding and main importance of this thesis is the identification of clinical risk 
factors for PGP. These clinical risk factors may provide a basis for developing targeted 
prevention and treatment strategies for PGP and thereby potentially reduce the numbers of 
women with PGP during and after pregnancy. About ⅓ of the women in the present cohort 
reported to have PGP 12 weeks postpartum, although several with low disability. From the 
studies in this thesis we do not know how many of these will recover over the subsequent 
months. It will be of interest to examine whether the clinical factors also represent a risk for 
pain and disability one year postpartum. 
 We have identified new clinical risk factors, responses to clinical tests and pain 
locations within the pelvic area. The next step would be to perform a prediction study, 
where the effect of the identified risk factors is studied, to confirm their suitability as 
predictors for PGP.  
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14 EPILOG 
This thesis began with initial questions concerning PGP, previous research and certain 
unanswered issues. Through the work done in conjunction to the present thesis, it does 
appear that some of these issues have been partially answered and new knowledge has been 
acquired.  
 The results from the studies confirm that the prevalence of PGP is high, even when 
examined in a prospective design. Since more than 60 % of the pregnant women reported 
having pain in the pelvic area, this probably indicates that some pain and discomfort in this 
area during pregnancy is normal. The broad variation in affliction implies that the effect of 
the pain also varies to a great extent. We have documented that pregnancy itself has an 
effect on disability and that PGP gives an additive effect. Furthermore, we see that the use 
of graded scales as outcome measures has been valuable because it provides information 
about affliction. The results indicate that the degree of affliction should be focused upon in 
addition to the presence of PGP, in research as well as in clinical work. Focus on affliction 
may be helpful in developing priority strategies. Identification of clinical predictors may 
offer possibilities for developing new treatment strategies. The latter implies further 
research on treatment for PGP.  
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Abstract 
Background 
Recent studies have shown high prevalence rates for pelvic girdle pain (PGP) in pregnancy. 
Some risk factors for developing PGP have been suggested, but the evidence is weak. 
Furthermore there is almost no data on how findings from clinical examinations are related to 
subsequent PGP. The main purpose for this study was to study the associations between 
socio-demographical, psychological and clinical factors measured at inclusion in early 
pregnancy and disability or pain intensity in gestation week 30.  
Methods 
This is a prospective cohort study following women from early to late pregnancy. Eligible 
women were recruited at their first attendance at the maternity care unit. 268 pregnant women 
answered questionnaires and underwent clinical examinations in early pregnancy and in 
gestation week 30. We used scores on disability and pain intensity in gestation week 30 as 
outcome measures to capture the affliction level of PGP. Multiple linear regression analysis 
was used to study the associations between potential risk factors measured in early pregnancy 
and disability or pain intensity in gestation week 30. 
Results  
Self-reported pain locations in the pelvis, positive posterior pelvic pain provocation (P4) test 
and a sum of pain provocation tests in early pregnancy were significantly associated with 
disability and pain intensity in gestation week 30 in a multivariable statistic model. In 
addition, distress was significantly associated with disability. The functional active straight 
leg raise (ASLR) test, fear avoidance beliefs and the number of pain sites were not 
significantly associated with either disability or pain intensity. 
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Conclusions  
The results suggest that a clinical examination, including a few tests, performed in early 
pregnancy may identify women at risk of a more severe PGP late in pregnancy. The 
identification of clinical risk factors may provide a foundation for development of targeted 
prevention strategies.   
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Pelvic girdle pain – associations between risk factors in early pregnancy and disability 
or pain intensity in late pregnancy: a prospective cohort study 
 
Background 
Pelvic girdle pain (PGP) is common in pregnancy. Recent studies have shown that about 33-
50% of pregnant women report PGP before 20 weeks of gestation, and that the prevalence 
may reach 60-70% in late pregnancy [1-3]. Despite these high prevalence estimates, we have 
little knowledge about the risk factors for PGP in pregnancy. Previous studies have reported 
that strenuous work, a pre-pregnancy history of low back pain (LBP), previous PGP, and 
multipara are associated with PGP in pregnancy [4-9]. Associations between PGP and 
psychological variables such as catastrophizing, fear-avoidance beliefs and distress have also 
been reported [8,10]. However, the number of studies are limited and often hampered by 
either being retrospective or cross-sectional [7,8], or by lack of multivariable analyses in the 
prospective studies [4-6].  
 Moreover, the response variables used in previous studies have most often been 
dichotomous, such as presence of PGP or not, and did not necessarily reflect the severity of 
the condition. The importance of also using graded scales has recently been pointed out by 
Croft [11]. In a recent cross-sectional study we used graded scales and showed that women 
with combined symphysis pain and bilateral posterior pelvic pain in late pregnancy reported 
more disability than women with fewer pain sites in the pelvis [3]. Others have shown that 
women with this combination of pain locations were also less likely to recover postpartum 
than those with more limited pain distribution [12,13].  
 Clinical management would probably benefit from an early identification of women 
at risk for developing disabling symptoms later in pregnancy. A number of tests for pain 
provocation of different tissues and locations in the pelvis are commonly used and 
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recommended [14]. Although both pain provocation tests and functional tests have most often 
been used for diagnostic purposes [13,15-17], they might also detect processes at an early 
stage. Previous studies of PGP during and after pregnancy have reported that positive scores 
on the posterior pelvic pain provocation (P4) test and the functional Active Straight Leg Raise 
(ASLR) test were associated with disability [3,18,19] and pain [16,18,19]. Furthermore, when 
blinded assessors were used, relative high frequencies of positive responses to the tests were 
also reported for pregnant women without pain in the pelvic area [3] . These results could 
either indicate low specificity or alternatively that the tests could detect subclinical afflictions 
and thus be valuable in early identification of those at risk for more severe afflictions.   
We established a cohort of pregnant women to study the associations between socio-
demographical, psychological and clinical factors measured at inclusion in early pregnancy 
and disability or pain intensity in gestation week 30.  
 
Methods 
This is a prospective cohort study following pregnant women in Norway from early 
pregnancy to gestation week 30.  
 
Procedure 
 The Norwegian public health system offers all women free health services during pregnancy 
and most women seek special maternity care units (MCUs) for this purpose. We collaborated 
with four public MCUs in this study, one was located in central Oslo (capital, about 580 000 
inhabitants), and the other three covered one entire community (about 24 000 inhabitants) just 
outside Oslo. Eligible participants were Norwegian-speaking women, who registered at these 
four MCUs between January 2006 and June 2007. Women not expected to have a normal 
pregnancy (as determined by the midwives) were excluded. Out of 385 eligible women, 326 
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gave their informed consent for participation. Out of these 326 women, 280 were included 
before they reached 20 weeks of gestation, and were thus defined as being in early pregnancy 
(figure 1). From the time of inclusion to gestation week 30, there were 3 drop-outs and 9 
miscarriages among the 280 women included early, thus 268 women participated in gestation 
week 30 and these constituted our study sample.  
After inclusion all answered a comprehensive questionnaire assessing 
sociodemographic variables, pain locations, pain intensity and disability, distress, and fear-
avoidance beliefs. The questionnaire also included questions on general health, health-related 
quality of life, health locus of control, use of contraceptives, other complaints, and physical 
activities, variables that were not used in this part of the study. The registered gestation week 
refers to the week the women were included to the study and completed the questionnaire.  
  All women were clinically examined in early pregnancy by one of two 
physiotherapists with post-gradual education in manual therapy. This examination was 
performed as closely to the inclusion date as possible. Mean time difference between 
answering the questionnaire and being examined was 1.1 week (SD 1.7 weeks). The clinical 
examination included six pain provocation tests for the pelvic joints as well as the functional 
ASLR test and Beighton score for hyper mobility. Other clinical tests were also included, but 
were not used in this part of the study. The examiner was blinded for all questionnaire data. In 
gestation week 30, the women filled in a new questionnaire assessing the same elements as at 
inclusion and underwent a corresponding clinical examination. Data from the clinical 
examination in gestation week 30 was not used in this part of the study.  The Regional 
Committee for Medical Research Ethics and the Norwegian Social Science Data Services 
gave formal approval for the study. 
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Measurements of response variables 
Disability and pain intensity were obtained from questionnaire data collected in gestation 
week 30. Disability was measured by the Disability Rating Index (DRI), consisting of twelve 
visual analogue scales (VAS) measuring the ability to perform activities of daily living [20]. 
The scales ranged from 0 – 100 mm, where the end points were “ability to perform activity 
without restriction” and “inability to perform the activity”, respectively. The twelve activities 
were: dressing without help, outdoor walks, climbing stairs, sitting for a longer time, standing 
bent over a sink, carrying a bag, making a bed, running, do light work, do heavy work, lifting 
heavy objects, participating in exercise/sport. DRI was calculated as the mean of the twelve 
scales. In order to allow the assessment of disability in women with and without PGP, we 
chose DRI because it measures disability by limitations in daily activities independent of pain. 
DRI has previously been applied in studies of pregnant women [2,10], and we also evaluated 
the items to be adequate for this group. 
Pain intensity was measured by the response to the following question: “How strong is 
your worst evening pain before going to bed?”  Since PGP has been suggested to increase 
with activity [9,17], we chose the intensity of the worst evening pain as the most relevant 
measure for their experienced degree of pain affliction. The response was measured by a 0-
100 mm VAS and the end points were “no pain” and “unbearable pain”.  
 
Measurements at inclusion in early pregnancy 
Potential risk factors for PGP were measured by questionnaire and clinical examination at 
inclusion in early pregnancy.  
Questionnaire data: 
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Socio-demographical data included age (years), parity (0, 1, ≥2 children), marital status 
(single, married/cohabitant), education (≤12 years of school attendance, ≤4 years at 
university, > 4 years at university), use of contraceptive pills last year before pregnancy (yes, 
no), smoking (yes, no), physical activity before pregnancy (none, < 2, 2 - 4, > 4 hours per 
week), full time work (yes, no). Pre-pregnancy body mass index (BMI, weight/height2) was 
calculated from self-reported height and weight. 
The working condition was identified from the question: “How would you describe 
your work situation?” With four response alternatives: 1) Most of the time seated; 2) I have to 
walk a lot; 3) I walk and lift objects; 4) Heavy work. PGP was assumed to increase with 
weight bearing activities like walking and lifting objects [6,9]. Working condition was 
categorized as mostly seated work (response alternative 1) and heavy work (response 
alternatives 2-4).  
 The Hopkins Symptom Check List (HCSL-25) was used to measure distress (self-
reported symptoms of anxiety, depression and somatisation) [21]. Twenty-five symptoms 
were recorded on a scale from 1 (not bothered) to 4 (extremely bothered). The average value 
was calculated to obtain the HSCL-25 score. We used a cut off value of 1.75 as established 
for women by Sandanger and co-workers (1998), and the cut-off reflected non-specific 
distress, rather than a psychiatric diagnosis [22].  
Fear avoidance beliefs was measured by the modified Fear Avoidance Beliefs 
Questionnaire (mFABQ) [23]. This includes four of the items from the part concerning 
activity in the original Fear Avoidance Beliefs Questionnaire [23,24]. We chose the modified 
version because it was possible to answer also by individuals without pain. In accordance with 
the work from Linton and co-workers [23], the following instructions were given in the 
questionnaire: “Some women are likely to be afflicted by pain in the back and pelvis during 
pregnancy. For research purposes, we would like to know if you believe that there is a 
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relationship between such afflictions and activities. Please circle the number on the scale that 
best corresponds to your belief for each of the following statements”. The scale ranged from 0 
(total disagreement), to 6 (total agreement), and the total score on mFABQ ranged from 0-24 
[23]. 
Pain locations within the pelvic area (PGP) were determined by a pain drawing filled 
in by the women before the clinical examination. After the examination, the women were 
asked to point out the pain sites on their body and, if necessary, the examiner corrected the 
pain drawing to reflect the areas pointed out. The pain locations in the pelvic area were 
subsequently coded: no PGP, pain in symphysis only, only posterior pain (uni- or bilateral), 
combined symphysis pain and unilateral posterior pain, and combined symphysis pain and 
bilateral posterior pain [3,25]. The two latter categories were collapsed in the analyses 
(combined symphysis and posterior pain) because of low frequencies. 
The number of pain sites was calculated from the questions where the women were 
asked if they have pain (yes, no) in the neck, shoulder and arms, between the shoulder blades, 
in the knees. The sum score (0-4) was used in the analyses. Pain located in the area of the 
lower back and the pelvis was not included in this sum. 
Pre-pregnancy history of LBP was identified from the question: “Have you suffered 
from LBP before you were pregnant (yes, no)?”  
Clinical examination: 
Beighton score was used as a measure for joint laxity and consists of 9 tests [26,27]: 
hyperextension of the knees (yes, no), hyperextension (>10▫) of the elbows (yes, no), passive 
apposition of the thumbs to the flexor aspect of the forearm with straight elbow (yes, no), 
passive hyperextension of the 5th metacarpophalangeal joints ≥ 90▫ (yes, no) , forward flexion 
of the trunk, with knees straight, so that the palms of the hands rest easily on the floor (yes, 
 10 
no). The angles were measured with a goniometer.  A sum score (0-9) was made of the results 
of all the tests and hypermobility was defined as a sum score of four and above [26]. 
We used one functional test, the ASLR test, and six pain provocation tests: the P4 test, 
the distraction test, the compression test, the Patrick Faber test, the palpation test of the 
symphysis pubis and the long dorsal sacroiliac ligament (LDL). All the tests have been 
commonly used and have shown moderate to excellent inter-rater reliability [17,18,28,29]. 
The active straight leg (ASLR) test [18]:  The ASLR test was performed with the 
women in a supine position with straight legs and feet about 20 cm apart. The women lifted 
each leg separately about 20 cm above the couch. She was asked to score the difficulty on a 
six-point scale from 0 (not difficult to lift) to 5 (impossible to lift). The scores on both sides 
were added and the total score ranged from 0-10. In accordance with previous studies, we 
considered an ASLR sum score of 4 and above as a positive test [30,31]. 
The Posterior Pelvic Pain Provocation (P4) test [17]: The P4 test was performed with 
the women in a supine position. The hip and knee on the tested side were flexed to 90◦. The 
examiner stabilized the contra lateral side of the pelvis while a graded force was applied on 
the flexed knee into the pelvis along the longitudinal axis of femur. Adduction of the hip was 
avoided. It was recorded whether a familiar pain was felt in the posterior part of the pelvis on 
the provoked side (yes, no). Both left and right side were tested and scored separately. 
Distraction test: The women were examined in supine position. The examiner applied 
cross-armed pressure to the anterior superior iliac spines (ASIS) directed laterally. This 
procedure was assumed to stretch the anterior sacroiliac joint ligaments and to give 
compression in the dorsal part of the sacroiliac joints. The pain response was recorded (yes, 
no). 
Compression test: The woman were examined in side lying position, knees and hips 
slightly flexed. Pressure was applied vertically into the pelvis when the examiner leaned her 
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chest against the uppermost iliac crest. The test was assumed to stretch the posterior sacroiliac 
joint ligaments and compress the anterior part of the sacroiliac joints. The pain response was 
recorded (yes, no). Both sides were tested and scored separately.  
Patrick-Faber test: The women were examined in supine position. The examiner led 
the ipsilateral leg into flexion, abduction and external rotation so that the heel rested on the 
opposite kneecap. The examiner stabilized the contralateral side of the pelvis to ensure that 
the lower back stayed in a neutral position. The ipsilateral knee was lowered against the table 
and the examiner applied a light overpressure to the subject’s knee. It was assumed that both 
the anterior sacroiliac ligament and the hip joint were stressed [32,33]. The pain response was 
recorded (yes, no). Both sides were tested and scored separately.  
Palpation of the pubic symphysis: The women were examined in supine position. The 
examiner applied gentle pressure to the pubic symphysis with her hand (flat fingers). If the 
pressure caused pain that persisted more than 5 seconds after removal of the hand, it was 
recorded as pain (yes, no). 
Palpation of the long dorsal sacroiliac ligament test: The women were examined in 
side lying position and the examiner palpated the long dorsal sacroiliac ligament at her 
uppermost side, caudal of the posterior-superior iliac spine. The test was positive if the 
palpation provoked pain and recorded (yes, no). Both sides were examined and scored 
separately.  
Apart from the P4 test, a sum score was calculated from numbers of positive responses 
to pain of all the above described pain provocation tests, ranging from 0 (all negative) to 8 (all 
positive). We decided to use the responses on the P4 test as a single response and not as part 
of a sum; based on the tests relevance for PGP reported in previous studies [17,34]. 
 
 12 
Statistics 
Descriptive data are given as frequencies, percentages, means and standard deviations (SDs) 
or medians and ranges. Multiple linear regression analysis was used to study the associations 
between potential risk factors measured in early pregnancy and DRI or pain intensity in 
gestation week 30. Associations between the explanatory variables as well as between the 
explanatory variables and each of the response variables were studied by Pearson correlation 
coefficients. The explanatory variables showing significant relationship with the response 
variable were entered into a multiple regression model. The best subsets of explanatory 
variables were selected through exclusion of the variables with the smallest contribution to the 
model (the largest p-values). Two adjusted models are presented for each of the response 
variables, without (model 1) and with (model 2) adjustment for DRI or pain intensity at 
inclusion in early pregnancy. The residuals were examined to check model assumptions. The 
statistical analyses were conducted in SPSS version 16.0 and a 5% level of significance was 
used.  
 A continuous variable was the main outcome in the power calculations. The level of 
significance was set to 5% (two-sided) and the power 80%. Assuming a correlation of 
medium size, 0.3, in the population, a sample size of 85 is required for assessing significance 
of a correlation coefficient in the sample [35]. In a multiple regression analysis with five 
independent variables, the required sample size is 91 to detect a medium effect size of 0.15 
(R2/(1-R2)) [35].  
 
Results 
Mean gestation week at inclusion in early pregnancy was 14 weeks (SD 3 weeks) for the 268 
women participating in this study. They were 18 to 45 years old and 59% were pregnant with 
their first child. Characteristics of the participants are presented in table 1. A total of 59 
 13 
women declined participation in the cohort study. There were no difference between 
participants and non participants with regard to age (mean 31 years and SD 4 years in both 
groups) and marital status. The non-participants (n=59) were asked about participation in 
mean gestational week 15 (SD 6 weeks), and 44% were nulliparous. The women excluded 
from analyses (n=46) due to inclusion later than gestation week 20 were a little older (mean 
age 32 years, SD 4) and 77% were nulliparous.  
Fifty percent of the participants reported pain in the pelvic area in early pregnancy and 
most of them reported posterior pain only (39%) (table 2). Pain in the symphysis only and 
combined symphysis and posterior pain were reported by 4% and 7% of the women, 
respectively. The frequencies of negative responses were high on all the clinical tests (54 – 
94%). The sum of pain provocation tests had a median value of 1 (range 0, 6) (table 2). Both 
DRI and pain intensity increased from early pregnancy to gestation week 30, and showed 
large variation among the women (table 2).  
The correlation coefficients between the potential risk factors and DRI ranged from  
-0.07 to 0.54 and between potential risk factors and pain intensity ranged from -0.10 to 0.46 
(table 3). The correlation coefficients between the potential risk factors ranged from -0.25 to 
0.56 and did not suggest collinearity (data not shown). Pain intensity and DRI in gestation 
week 30 were significantly correlated (r= 0.63, p<0.001) (table 3).   
Pre-pregnancy BMI, smoking, physical activity before pregnancy, full time work and 
Beighton score for hypermobility were not significantly associated with DRI in gestation 
week 30 in the bivariate analysis (0.16≤p≤0.64). Physical activity before pregnancy, full time 
work and Beighton score for hypermobility were not significantly associated with pain 
intensity in gestation week 30 in the bivariate analysis (0.38≤p≤0.98). These variables were 
not entered in to the respective multivariable models. Age, gestation week, pre-pregnancy 
LBP, and work condition were not significantly associated with the response variables 
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(0.11≤p≤0.65), but were entered into the multivariate models based on associations reported 
in previous studies [4-9]. 
In the multivariable model, pain locations, P4 test, sum of pain provocation tests, and 
HSCL-25 in early pregnancy were significantly associated with DRI in gestation week 30 
(Table 4). Age, parity, marital status, education, use of contraceptive pills, the ASLR test, pre-
pregnancy history of LBP, work condition, number of pain sites and mFABQ in early 
pregnancy were not significantly associated with DRI in gestation week 30 in the 
multivariable analyses (0.08≤p≤0.98). No significant interactions between the explanatory 
variables were found (0.21≤pinteraction≤0.97). When we adjusted for DRI in early pregnancy, R2 
increased from 0.26 (model 1) to 0.37 (model 2) and the sum of pain provocation tests and 
HSCL-25 were no longer significant (p=0.26 and p=0.49, respectively) (Table 4). Additional 
adjustment for gestation week at inclusion did not change the results.  
In the multivariable model for pain intensity in gestation week 30 similar results were 
found (table 5). The same variables were significant except for HSCL-25. Age, parity, marital 
status, education, use of contraceptive pills, pre-pregnancy BMI, smoking, the ASLR test, 
pre-pregnancy history of LBP, work condition, number of pain sites, and mFABQ in early 
pregnancy were not associated with pain intensity in gestation week 30 in the multivariable 
analysis (0.07≤p≤0.80). No significant interactions between the explanatory variables were 
found (0.25≤pinteraction≤0.77). Adjustment for pain intensity in early pregnancy increased the 
R2 from 0.29 (model 1) to 0.33 (model 2) and the sum of pain provocation tests in early 
pregnancy was no longer significant (p=0.23) (table 5). Additional adjustment for gestation 
week in early pregnancy did not change the results.  
  The effect estimates of each response variable were relatively large in both models, 
although the 95% confidence intervals were wide. Yet the effect estimates seemed to be 
higher for pain intensity compared with DRI. For instance our data shows that pain intensity 
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in late pregnancy is 40.4 (95% CI: 24.4, 56.6) higher when pain was present in the symphysis 
only, compared with having no pain in early pregnancy and adjusted for P4 test and sum of 
pain provocation tests (table 5, model 1).  
 
Discussion 
The main results from this study were that pain locations in the pelvis, positive P4 test and 
sum of pain provocation tests in early pregnancy were significantly associated with disability 
and pain intensity in late pregnancy. In addition, distress was significantly associated with 
disability. The functional test ASLR, fear avoidance beliefs and the number of pain sites were 
not significantly associated with neither disability nor pain intensity. 
The risk factors identified in this study differ from those that have been reported 
before. Strenuous work, pre-pregnancy history of LBP and parity have previously been 
identified as risk factors for PGP in studies applying bivariate statistics [4-6] and 
multivariable models [9].  In our bivariate correlation analyses, the first two variables were 
not significantly associated to neither disability nor pain intensity in gestation week 30, while 
parity was. None of the variables were significant in the multivariable analyses. This could be 
due to difference in design or to the use of different levels of statistical methods. One possible 
explanation for the difference could be that previous studies have often recorded the risk 
factors retrospectively, late in pregnancy and after the onset of symptoms. Hence, the 
women’s reporting of these factors might be biased by pain [7,8]. The prospective design of 
the present study ensured that this possible bias was avoided. At the time of inclusion and 
measurement of the risk factors, none of the women had defined their symptoms as a problem 
and they were not seeking treatment.   
It is also noteworthy that the results of the functional ASLR test measured in early 
pregnancy, used with a distinction between those with  strong affliction and those with none 
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or lesser affliction, was not significantly associated with disability. This might indicate that 
severe impairment of motor control and movement of the legs relative to the pelvis was not 
important for the development of PGP. On the other hand, the response to the P4 test was 
identified as a risk factor for both pain intensity and disability. Since this test is supposed to 
elicit a distinct located pain deep in the gluteal area [17], it seems that affliction in the 
posterior pelvis has an impact on the course. This is, however, partly contradicted by the data 
from pain locations. Self-reported pain only in the symphysis in early pregnancy had about 
the same impact on disability and pain intensity in gestation week 30 as did combined 
symphysis pain and posterior pain. Moreover posterior pain (without symphysis pain) in early 
pregnancy was not significantly associated with disability and pain intensity in gestation week 
30. Since this group was the largest, the lack of effect can hardly be explained by lower test 
power than the other pain locations. Although the confidence intervals were wide, our data 
indicate that subclinical afflictions in both anterior and posterior part of the pelvis are of 
importance for development of pain and disability. Hence, our data suggest that symphysis 
pain can be an early indicator or precursor for pain development in other areas of the pelvis. 
Interestingly, the association seems to disappear when pain location and disability are 
measured simultaneously in late pregnancy [3]. 
When we included disability or pain intensity assessed in early pregnancy in the 
multivariable models, some explanatory variables were no longer significant. This means that 
these variables were not risk factors for the change in disability or pain intensity. However, 
from a clinical point of view it is more important to identify risk factors for disability and pain 
intensity late in pregnancy than the change from early pregnancy. This is supported by the 
data showing an increased DRI already in early pregnancy compared with healthy non-
pregnant women [20]. 
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Several of the previously identified risk factors for PGP in pregnancy are similar to 
those reported for LBP and for other musculoskeletal disorders and are not specific for PGP 
[36,37]. These comprise socio-demographical factors, previous history of LBP, strenuous 
work and high level of distress. In contrast, positive response to the P4 test has been shown to 
be sensitive and specific for PGP [17]. Also the pattern of pain locations within the pelvis is 
probably specific for PGP, and one might therefore hypothesize that both the P4 test and pain 
locations are “condition specific” risk factors for PGP.  
The response variables used in this study were measured as scale values whereas 
previous studies have used dichotomous responses for example reporting PGP or not. From 
the large variation in responses shown when using scales in the present study, one might 
question to what extent the dichotomous response variables actually reflects important 
affliction. The dichotomous response variables have resulted in very high prevalence rates for 
PGP in pregnancy [1,2,10,25]. We have recently found that the variability in DRI was large 
both for women reporting and not reporting PGP [3]. In order to capture associations to this 
large range of affliction, the used scales seem to provide additional information than the 
dichotomous responses.  
Previous studies have shown associations between distress, fear avoidance beliefs and 
activity limitations in patients with LBP [38-42], and also that distress contributed to physical 
activity and work loss in an acute sample of LBP patients [36]. Our results showed that 
distress contributed into the model for disability but not for pain intensity. Interestingly the 
effect of HSCL-25 on disability in gestation week 30 disappeared when we controlled for 
disability at inclusion. As in the study from Grotle and co-workers of acute LBP [43], fear 
avoidance beliefs was not identified as a risk factor for either disability or pain intensity. 
Over the years, there has been a growing evidence for predictive effect of widespread 
pain on long term changes in work disability [44]. Furthermore, it has also been reported that 
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the risk of long-term work disability was lower for persons with localized LBP compared with 
persons with LBP combined with pain in other bodily areas. The risk for long-term work 
disability increased with the latter [45,46]. We included number of pain sites (excluding low 
back and pelvic area) in the multivariable analyses, and found that it did not contribute in any 
of the models. The lack of effects may be due to the small number of possible pain sites. 
However, it is also possible that PGP in pregnancy is a specific condition characterized by a 
rather short course compared with other musculoskeletal pain conditions. Most of the women 
recover shortly after delivery. One might thus speculate that multiple pain sites are not of 
importance for development of PGP in pregnancy, but could still be of importance for non-
recovery from PGP postpartum.  
The present study has several strengths, including the use of a prospective design, 
continuous response variables and multivariable statistics. Furthermore the implementation of 
clinical risk factors, use of blinded examiners and the follow-up of all pregnant women in the 
cohort independent of having PGP or not also strengthen the study.  
A limitation that should be considered when interpreting the results is the limited 
numbers of women in some of the groups. However, even though the confidence intervals are 
wide, the findings indicate that the risk factors are of importance. On the other hand, lack of 
significant results should be interpreted with caution. 
Another possible weakness could be the representativeness. The women participating 
in the cohort were about the same age and in the same gestation week as women declining 
participation. Women who were excluded from analyses due to late inclusion were also about 
the same age. The average age of women giving birth in Norway have been 30.3 years (2006 
– 2007) [47] i.e., almost similar as in our cohort. There were some differences in the 
percentage of nulliparous women in the non-participant group, the excluded group and the 
participants (44%, 77% and 59% respectively). The number of nulliparous women in the 
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cohort was also slightly higher than among Norwegian women (59% vs 42%). We cannot 
exclude the possibility that another cohort of pregnant women in Norway, would result in 
somewhat different results with regard to prevalence of pain locations and positive clinical 
tests. However, the associations between them are expected to be similar.  
 
Implications 
Even though most women recover from PGP shortly after delivery, it has been shown that a 
number of women report pain for longer time periods and that some of them have serious 
problems [48-50]. Hence it seems important to identify risk factors for development of PGP in 
pregnancy that could contribute to better management and thereby prevent persistent 
disability after delivery. Risk factors identified in previous studies, such as parity and 
strenuous work can hardly be treated or managed for prevention purposes. The identification 
of the clinical risk factors in the present study therefore opens up new possibilities for 
management. Prevention and treatment of PGP in pregnancy would have considerable 
implications for the women, but also for the society in terms of productivity and health costs. 
However, it remains to be seen whether the risk factors identified in the present study are of 
clinical value in treatment and prevention of PGP.  
 
Conclusions  
In conclusion, we have found that pain locations in the pelvis, bilateral positive P4 test, and 
sum of pain provocation tests in early pregnancy were significantly associated with disability 
and pain intensity in gestation week 30. The effect estimates were relatively large. 
Furthermore distress was significantly associated with disability, but not with pain intensity. 
Fear avoidance beliefs were not significantly associated with any of the responses. These 
results thus suggest that a clinical examination including a few tests performed in early 
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pregnancy may identify women at risk of a more severe PGP late in pregnancy. The 
identification of clinical risk factors may provide a foundation for development of targeted 
prevention strategies.  
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Figure 1 The study sample 
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Table 1 Characteristics of the women at inclusion in early pregnancy (n=268) 
 
  Frequency (%) Mean (SD) 
Age (years)   31 (4) 
Parity  0 157 (59)  
 1 86 (32)  
 ≥2  25 (9)  
Gestation week   14 (3)  
Marital status (single)  7 (3)  
Education ≤ 12 years school attendance 46 (17)  
 ≤4 years university 113 (42)  
 >4 years university 109 (41)  
Contraceptive pills, year before 
pregnancy (yes) 
  
103 (38) 
 
Pre-pregnancy BMI (kg/m2)   23.3 (3.5) 
Smoking (yes)  11 (4)  
Physical activity before pregnancy None 11 (4)  
 < 2 hours per week 84 (31)  
 2 - 4 hours per week 138 (52)  
 > 4 hours per week 34 (13)  
Full time worker (yes)  228 (85)  
Heavy work (yes)  96 (36)  
mFABQ (0-24)   9.3 (3.8) 
HSCL-25 (score ≥1.75)  38 (14)  
Pre-pregnancy history of LBP (yes)  131 (49)  
 
 
BMI, Body Mass Index; mFABQ, modified Fear Avoidance Beliefs questionnaire; HSCL-25, Hopkins Symptom 
Check List; LBP, Low Back Pain
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Table 2 Distribution of possible risk factors and outcome variables. (n=268) 
  Frequency (%) Median (range) 
Beighton score  Normal (sum<4) 46 (17)  
 Hypermobile (sum≥4) 222 (83)  
Pain locations No pain 135 (50)  
 Pain in symphysis only 11 (4)  
 Posterior pain only 105 (39)  
 Combined symphysis and posterior pain 17 (7)  
P4 test Negative 161 (60)  
 Unilateral positive 53 (20)  
 Bilateral positive 54 (20)  
ASLR test  sum<4 240 (90)  
 sum ≥4 28 (10)  
Distraction test Negative 207 (77)  
 Positive 61 (23)  
Compression test Negative 251 (94)  
 Unilateral positive 15 (5)  
 Bilateral positive 2 (1)  
Patrick-Faber test Negative 191 (72)  
 Unilateral positive 39 (14)  
 Bilateral positive 39 (14)  
Palpation of pubic 
symphysis 
Negative 241 (90)  
 Positive 27 (10)  
Palpation of LDL Negative 145 (54)  
 Unilateral positive 41 (15)  
 Bilateral positive 79 (30)  
Sum of pain provocation 
tests 
  1.0 (0,6) 
DRI in early pregnancy   13 (0,93) 
DRI in gestation week 30   36 (0,81) 
Pain intensity in early 
pregnancy (worst evening 
pain) 
   
0 (0,82) 
Pain intensity in gestation 
week 30 (worst evening 
pain) 
   
14 (0,99) 
P4 test, Posterior Pelvic Pain Provocation test; ASLR test, Active Straight Leg Raise test; LDL, Long Dorsal 
Sacroiliac Ligament 
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Table 3. Correlation between outcome variables and possible predictors measured at inclusion 
in early pregnancy (n=268) 
   
  
DRI gestation week 30 
 
Pain intensity gestation week 30 
Pain intensity gestation week 30 (worst evening 
pain,VAS) 
0.63***  
Age (years) -0.07 -0.10 
Parity (0, 1, 2 or more) 0.15* 0.18** 
Gestation week in early pregnancy 0.03 -0.04 
Civil status (married, cohabitant; yes, no) 0.14* 0.22*** 
Education (≤12 years of school attendance , ≤4 
years university, >4 years university) 
0.19** 0.17** 
Contraceptive pills, year before pregnancy (yes, no) -0.13* -0.04 
Pre-pregnancy BMI (kg/m2) 0.09 0.12* 
Smoking (yes, no) 0.06 0.12 
Physical activity before pregnancy (none, <2, 2-4, 
≥4 hours per week) 
-0.05 -0.001 
Full time worker (yes, no) 0.05 0.09 
Work condition (mostly seated/heavy work) 0.03 0.06 
Beighton score for hypermobility 0.01 -0.06 
Pain locations (no pain, symphysis pain, posterior 
pain, combined symphysis and posterior pain) 
0.36*** 0.44*** 
P4 test (bilateral negative, uni-/bilateral positive) 0.41*** 0.39*** 
Sum of pain provocation tests (0-8) 0.40*** 0.40*** 
ASLR test (<4, ≥4) 0.18** 0.11 
HSCL-25 (<1.75, ≥1.75) 0.26*** 0.15* 
DRI in early pregnancy (0-100) 0.54*** 0.34*** 
Pain intensity in early pregnancy (worst evening 
pain, VAS) 
0.44*** 0.46*** 
Pre-pregnancy LBP (yes/no) 0.09 0.10 
Number of pain sites (0-4) 0.19** 0.14* 
mFABQ (0-24) 0.18** 0.10 
Pearson’s correlation coefficient; ***p≤0.001, **0.001<p≤0.01 *0.01<p≤0.05 
 
VAS, Visual Analogue Scale; BMI, Body Mass Index; P4 test, Posterior Pelvic Pain Provocation test; ASLR 
test, Active Straight Leg Raise test; HSCL-25, Hopkins Symptom Check List; DRI, Disability Rating Index; 
LBP, Low Back Pain; mFABQ, modified Fear Avoidance Beliefs Questionnaire 
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Table 4 Associations between disability in gestation week 30 and risk factors measured in 
early pregnancy (n=268). 
 
 Crude estimates Adjusted estimates; model 1 Adjusted estimates; model 2 
 β
1
 (95% CI2) p-value β1 (95% CI2) p-value β1 (95% CI2) p-value 
Pain locations 
No pain 
 
Reference 
 
<0.001 
 
Reference 
 
0.007 
 
Reference 
 
0.03 
Symphysis pain only 17.7 (6.8, 28.6)  14.0 (3.7, 24.1)  11.8 (2.3, 21.2)  
Posterior pain only 10.7 (6.2, 15.3)  4.8 (-0.2, 9.6)  3.4 (-1.0, 7.8)  
Combined symphysis 
pain and posterior 
pain 
 
24.5 (15.6, 33.5) 
  
11.8 (2.6, 21.0) 
  
8.4 (-0.07, 17.0) 
 
P4 test 
Negative 
 
Reference 
 
<0.001 
 
Reference 
 
<0.001 
 
Reference 
 
<0.002 
Unilateral positive 8.0 (2.6, 13.5)  2.2 (-3.4, 7.9)  3.3 (-1.9, 8.6)  
Bilateral positive 19.8 (14.3, 25.2)  12.0 (6.0, 18.0)  10.0 (4.4, 15.6)  
Pain provocation tests 
(sum) 
5.3 (3.9, 6.7) <0.001 1.7 (0.3, 3.0) 0.02 0.7 (-0.5, 2.0) 0.26 
HSCL-25 
<1.75 
 
Reference 
 
<0.001 
 
Reference 
 
0.006 
 
Reference 
 
0.49 
≥1.75 14.0 (7.6, 20.3)  8.2 (2.3, 14.0)  2.0 (-3.7, 7.7)  
DRI in early 
pregnancy 
0.6 (0.5, 0.7) <0.001 - - 0.5 (0.3, 0.6) <0.001 
1 Estimated regression coefficients, 2 CI, confidence interval. DRI, Disability Rating Index; P4 
test, Posterior Pain Provocation test; HSCL-25, Hopkins Symptom Check List  
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Table 5 Associations between pain intensity (worst evening pain) gestation week 30 and risk 
factors measured in early pregnancy (n=268). 
 Crude estimates Adjusted estimates; model 1 Adjusted estimates; model 2 
 β
1
 (95% CI2) p-value β1 (95% CI2) p-value β1 (95% CI2) p-value 
Pain locations 
No pain 
 
Reference 
 
<0.001 
 
Reference 
 
<0.001 
 
Reference 
 
<0.001 
Symphysis pain only 44.2 (27.7, 60.6)  40.4 (24.4, 56.5)  35.5 (19.7, 51.1)  
Posterior pain only 23.5 (16.6, 30.3)  15.3 (7.8, 22.8)  11.8 (4.3, 19.2)  
Combined symphysis 
pain and posterior 
pain 
 
40.5 (26.9, 54.0) 
  
26.0 (11.6, 40.4) 
  
16.5 (1.8, 31.1) 
 
 
P4 test 
Negative 
 
Reference 
 
<0.001 
 
Reference 
 
0.07 
 
Reference 
 
0.01 
Unilateral positive 16.5 (7.7, 25.2)  5.8 (-3.1, 14.8)  6.1 (-2.6, 14.7)  
Bilateral positive 28.6 (19.9, 37.3)  15.2 (5.8, 24.6)  13.7 (4.5, 22.8)  
Pain provocation tests 
(sum) 
6.3 (4.5, 8.0) <0.001 2.3 (0.3, 4.4) 0.03 1.3 (-0.8, 3.3) 0.23 
Pain intensity in early 
pregnancy (worst 
evening pain) 
0.7 (0.5, 0.8) <0.001 - - 0.4 (0.2, 0.5) <0.001 
1 Estimated regression coefficients, 2 CI, confidence intervals. P4, Posterior Pelvic Pain 
Provocation test 
 
 
  
 
9 miscarriages and 3 
drop-out 
385 eligible women from 4 Maternity Care Units 
59 denied participation 
326 women included 
 
46 recruited after 
gestation week 20 
Early pregnancy:  
280 women    
Questionnaire and clinical 
examination 
Gestation week 30:  
268 women    
Questionnaire (and clinical 
examination) 
Figure 1
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Pelvic girdle pain; potential risk factors in pregnancy in relation to disability and pain 
intensity three months postpartum 
 
Abstract 
The objective of this prospective cohort study was to examine how results of clinical 
tests on women with PGP in late pregnancy were associated with disability and pain intensity 
12 weeks postpartum controlling for socio-demographical and psychological factors.  
Out of the 283 women clinically examined in gestation week 30, 179 were considered 
afflicted from PGP and constituted the study sample.  
Potential risk factors were assessed by questionnaires (at inclusion and in gestation 
week 30) and clinical examination in gestation week 30. The clinical examination included 
pain provocation tests for the pelvis as well as the active straight leg raise test. We used pain 
intensity and disability (disability rating index, DRI) as response variables, derived from 
questionnaires 12 weeks postpartum. 
Using multivariable linear regression analyses, sum of pain provocation tests and pre-
pregnancy LBP were significantly associated with DRI 12 weeks postpartum. Furthermore, 
sum of pain provocation tests and number of pain sites were significantly associated with pain 
intensity.   
In conclusion, we found that when including results of clinical tests as risk factors 
together with socio-demographical and psychological factors in multivariable regression 
models, the clinical risk factors are the ones that remain significant. These results are of 
clinical importance because they seem to have the potential to identify women with a poor 
prognosis.  
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Introduction 
Pelvic girdle pain (PGP) is a common musculoskeletal disorder during pregnancy and 
recent studies have reported that prevalence in late pregnancy may be above 50% (Gutke et 
al., 2006; Mogren, 2006; Robinson et al., 2010a). The prevalence of women with PGP falls 
substantially during the first 3 months postpartum, reaching about 25% (Ostgaard et al., 1996; 
Albert et al., 2001; Wu et al., 2004). About ⅕ of those with PGP postpartum are assumed to 
have serious problems and it would be clinically important to identify these women as early as 
possible.    
Recent studies suggest that pain location could be an important risk factor for 
sustained PGP postpartum (Albert et al., 2006; Gutke et al., 2008; Vollestad and Stuge, 2009). 
Gutke et al. reported that low back pain (LBP) in combination with PGP in early pregnancy 
predicted persistent pain 3 months postpartum (Gutke et al., 2008). Albert et al. reported a 
slower recovery postpartum among women with combined symphysis and bilateral posterior 
pelvic pain in pregnancy than among women with fewer pain locations (Albert et al., 2001).   
Clinical examinations, including functional tests and pain provocation tests for the 
pelvic joints, are most often used for diagnostic purposes, and the results have seldom been 
evaluated as risk factors for sustained PGP postpartum. However, one study reported that 
women with high numbers of positive pain provocation tests in late pregnancy were more 
likely to have PGP two years after delivery (Albert et al., 2001). Associations between the 
bilateral posterior pelvic pain provocation (P4) test in early pregnancy and the development of 
disability and pain intensity in late pregnancy have been reported (Robinson et al., 2010b). It 
is of interest to examine whether results of clinical tests may give information about the risk 
of sustained PGP postpartum. 
Previous studies have reported associations between postpartum PGP and pre-
pregnancy history of LBP, trauma to the pelvis, multipara, and heavy work loads, but the 
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evidence is limited (Ostgaard and Andersson, 1992; Breen et al., 1994; Turgut et al., 1998; 
Albert et al., 2001; To and Wong, 2003; Rost et al., 2006; Vleeming et al., 2008). Studies of 
LBP have shown that psychosocial factors and emotional distress are important for non-
recovery (Cedraschi and Allaz, 2005; Grotle et al., 2005), but such associations have seldom 
been studied for PGP (Vleeming et al., 2008). However, work dissatisfaction (Gutke et al., 
2008) and lack of belief in improvement (Vollestad and Stuge, 2009) have been reported as 
risk factors for non-recovery from PGP postpartum.  
Most previous studies have used women’s report of the presence or absence of PGP as 
response variables, without assessment of the degree of affliction (Albert et al., 2001; 
Mogren, 2006; Rost et al., 2006). We have previously reported large variations in disability, 
pain intensity, and consequently the impact on daily life, among women with PGP postpartum 
and in pregnancy (Stuge et al., 2004; Robinson et al., 2010a). It is therefore of interest to use 
disability and pain intensity as response measures postpartum.  
The main purpose of this study was to examine how clinical assessments in women 
with PGP in late pregnancy were associated with disability and pain intensity 12 weeks 
postpartum when we controlled for socio-demographical and psychological factors.  
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Materials and methods 
The present study is a prospective cohort study following pregnant women in Norway 
from their first contact with the health service (in pregnancy) till 12 weeks postpartum. The 
potential risk factors were assessed by questionnaires (at inclusion and in gestation week 30) 
and clinical examination in gestation week 30. The responses were derived from 
questionnaires 12 weeks postpartum. The examiner was blinded for all questionnaire data. 
The Regional Committee for Medical Research Ethics and the Norwegian Social Science 
Data Services gave formal approval of the study. 
 
The cohort 
The Norwegian public health service offers all women free health service during 
pregnancy and most women seek special maternity care units (MCUs) for this purpose. Our 
cohort comprised 326 pregnant women, recruited consecutively at their first appointment at 
four MCUs in the Oslo (capital city) area. They were 18 to 41 years old and 59% were 
pregnant for the first time. During the first 30 weeks of pregnancy nine women reported a 
miscarriage and three dropped out of the study (figure 1). The women were selected for a new 
examination in gestation week 30, based on a short questionnaire, including three questions 
about low back and pelvic pain, distributed by the midwives and answered by the women in 
gestation week 28. The women had either to be without symptoms of PGP and LBP, or to 
report pain located in the pelvic area or low back area once a week or more. Furthermore, the 
pain had to be provoked by sitting, standing or walking. Hence, at gestation week 30, 283 
women met and underwent a clinical examination. For the remaining 31 women (9 %) only 
questionnaire data were collected.  
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Measurements of response variables, 12 weeks postpartum 
Physical disability was assessed by the Disability Rating Index (DRI) (Salen et al., 
1994), scoring the ability to perform activities of daily living (dressing without help, outdoor 
walking, climbing stairs, sitting for a longer period, standing leaning over a sink, carrying a 
bag, making a bed, running, performing light work, performing heavy work, lifting heavy 
objects, participating in exercise/sport). These items were scored by visual analogue scales 
(VAS) ranging from 0 – 100 mm, with end points “ability to perform activity without 
restriction” and “inability to perform the activity”. We calculated DRI as the mean of the 
twelve scales. DRI has previously been applied in studies of pregnant women (Olsson and 
Nilsson-Wikmar, 2004; Olsson et al., 2009; Robinson et al., 2010a).  
We measured pain intensity by asking: “How intense is your worst PGP before going 
to bed?”  The response was measured by a 100 mm VAS, with end points:  “no pain” and 
“unbearable pain”. The intensity of worst evening pain was evaluated and used as the most 
relevant measure for pain affliction since PGP is said to increase with activity (Ostgaard et al., 
1994; Larsen et al., 1999).  
 
Measurements of potential risk factors 
Questionnaire data at inclusion: 
Socio-demographical data included age (years), parity (0, 1, >1 child), marital status 
(single, married/cohabitant), education (≤12 years, ≤4 years at university, > 4 years at 
university), smoking (yes, no), pre-pregnancy physical activity (none, < 2, 2 - 4, > 4 hours per 
week). Pre-pregnancy body mass index (BMI) was calculated from self-reported height and 
weight.  
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Questionnaire data at gestation week 30: 
Distress was assessed by the Hopkins Symptom Check List (HSCL) (Rickels et al., 
1976). Twenty-five symptoms were ranged on a scale from 1 (not bothered) to 4 (extremely 
bothered). The average value was calculated to obtain the HSCL-25 score.  
Fear avoidance beliefs were measured by the modified Fear Avoidance Beliefs 
Questionnaire (mFABQ) that can be answered also by individuals without pain (Linton et al., 
2000). The mFABQ includes four items from the section concerning physical activity in the 
original FABQ (Waddell et al., 1993; Linton et al., 2000). In accordance with the work by 
Linton et al. 2000, the introductory text was: “Some women are likely to be afflicted by pain 
in the back and pelvis during pregnancy. For research purposes, we would like to know if you 
believe that there is a relationship between such afflictions and activities.” For each item the 
scale ranged from 0 (total disagreement), to 6 (total agreement), and the sum score from 0 to 
24.  
 We determined pain locations within the pelvic area from pain drawings filled in by 
the women previous to the clinical examination in gestation week 30. After the examination, 
the women were asked to point out the pain sites on their body and, if necessary, the examiner 
corrected the pain drawing to reflect the areas pointed out. The pain locations in the pelvic 
area were subsequently coded: no PGP, pain in symphysis only, only posterior pain (uni- or 
bilateral), combined symphysis pain and posterior pain. 
We asked the women if they had pain in other bodily areas (yes, no). The areas were:  
the neck, shoulder and arms, between the shoulder blades, and the knees. The number of pain 
sites was added (sum score 0-4). Pain located in the area of the lower back and the pelvis was 
used as separate variables.  
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Pre-pregnancy history of LBP was identified from the question: “Have you suffered 
from LBP before pregnancy (yes, no)?”  
 
Clinical examinations in gestation week 30 
The active straight leg (ASLR) test (Mens et al., 2001):  The ASLR was performed 
with the women supine, straight legs and feet about 20 cm apart. The women lifted each leg 
separately about 20 cm above the couch. They were asked to score the difficulty on a six-
point scale from 0 (not difficult to lift) to 5 (impossible to lift). The scores on both sides were 
added and the sum ranged from 0-10.   
The Posterior Pelvic Pain Provocation (P4) test (Ostgaard et al., 1994): The P4 test 
was performed with the women supine. The hip and knee on the tested side were flexed to 
90◦. The examiner stabilized the contra lateral side of the pelvis while a graded force was 
applied on the flexed knee into the pelvis along the longitudinal axis of femur. Adduction of 
the hip was avoided. We recorded whether a familiar pain was felt in the posterior part of the 
pelvis on the provoked side (yes, no) (Ostgaard et al., 1994). Left and right side were tested 
and scored separately. 
Distraction test (Laslett and Williams, 1994): The women were examined in supine 
position. The examiner applied cross-armed pressure directed laterally to the anterior superior 
iliac spines. The pain response was recorded (yes, no). 
Compression test (Robinson et al., 2007): The women were examined in side lying 
position, knees and hips slightly flexed. Pressure was applied vertically into the pelvis when 
the examiner leaned her chest against the uppermost iliac crest. The pain response was 
recorded (yes, no). Both sides were tested and scored separately.  
Patrick-Faber test (Dreyfuss et al., 1996; Slipman et al., 1998): The women were 
examined in supine position. The examiner led the ipsilateral leg into flexion, abduction and 
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external rotation so that the heel rested on the opposite kneecap. The examiner stabilized the 
contralateral side of the pelvis to ensure that the lower back stayed in a neutral position. The 
ipsilateral knee was lowered against the table and the examiner applied a light overpressure to 
the subject’s knee. The pain response was recorded (yes, no). Both sides were tested and 
scored separately.  
Palpation of the pubic symphysis (Albert et al., 2000): The women were examined in 
supine position. The examiner applied gentle pressure to the pubic symphysis with her hand 
(flat fingers). If the pressure caused pain that persisted more than 5 seconds after removal of 
the hand, it was recorded as pain (yes, no). 
Palpation of the LDL (Vleeming et al., 2002): The women were examined in a side 
lying position and the examiner palpated the LDL at her uppermost side, caudal to the 
posterior-superior iliac spine. The test was positive if the palpation provoked pain and 
recorded (yes, no). Both sides were examined and scored separately.  
All tests have been commonly used with moderate to excellent inter-rater reliability 
reported (Ostgaard et al., 1994; Laslett and Williams, 1994; Mens et al., 2001; Robinson et 
al., 2007). 
Apart from the P4 test, we calculated a sum score of all positive responses from the 
described pain provocation tests, ranging from 0 (all negative) to 8 (all positive).  Based on 
the P4 test’s relevance for PGP reported in previous studies (Ostgaard et al., 1994; Gutke et 
al., 2009), we decided to use the P4 as a single response and not as part of a sum score. ASLR 
test was also used as a single response. 
 
The study sample 
The women were defined as afflicted in gestation week 30 if : 1) they reported to have 
PGP (yes, no) and/or had marked in the pelvic area on the pain drawing, and 2) they had a 
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DRI score above the 25 percentile for the 283 women being examined in gestation week 30 
(DRI>22). Both criteria were required, and resulted in 179 women included in the analyses. 
 
Statistical analyses 
Descriptive data is given as frequencies and percentages, means and standard 
deviations (SDs) or medians and ranges or interquartile ranges (IQR). Multiple linear 
regression analysis was used to study the associations between potential risk factors measured 
in pregnancy and DRI or pain intensity measured 12 weeks postpartum. Associations between 
the explanatory variables as well as between the explanatory variables and each of the 
response variables were studied by Spearman rank correlation coefficients. Explanatory 
variables significantly associated with the response variable or found important in previous 
studies were entered into a multiple regression model. The best subsets of explanatory 
variables were selected through exclusion of the variables with the smallest contribution to the 
model (the largest p-values). We divided pre-pregnancy BMI, ASLR, and HSCL-25 into two 
categories (<25, ≥25kg/m2) (WHO, 2010), (0, ≥1) (Mens et al., 2001) and (<1.75, ≥1.75) 
(Sandanger et al., 1998)  respectively, the sum of pain provocation test into four categories (0-
1, 2-3, 4-5, and 6-8 positive tests) and the number of pain sites into four categories (0, 1, 2,  
3-4). Interaction effects were tested, but real interactions may go undetected since this test 
lacks power (Kirkwood and Sterne, 2003). The residuals were examined to check model 
assumptions. Since a large number of the women reported low pain intensity and DRI 12 
weeks postpartum, we also repeated the multiple linear regression analyses with pain intensity 
and DRI ln transformed.  
In order to estimate the odds ratios for sustained PGP, we categorized the women as 
recovered or non-recovered 12 weeks postpartum based on a combination of pain and 
disability. Women were non-recovered if self-reported PGP and/or markings in the pelvic area 
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on the pain drawing was present and if the DRI was above 10 (Salen et al., 1994). A logistic 
regression model was used to study the associations between non-recovery and the same 
explanatory variables as used in the multiple linear regression analyses. We also used an 
alternative definition of non-recovery based on the definition described above, but in addition 
the pain intensity should be above ten. The results from the logistic regression model with the 
latter response variable were similar; hence these results are not presented.  
The statistical analyses were conducted in SPSS version 16.0 and a 5% level of 
significance was used.  
 
Results 
Four percent of the women were single, 5% were smokers and 50% reported a pre-
pregnancy history of LBP (table 1). The frequencies of positive responses at gestation week 
30 were high on four of the provocation tests (54 – 77%) (table 2). Lower frequencies were 
observed for the compression test (30%) and the palpation of the pubic symphysis (17%). 
Sum of pain provocation tests had a median value of 4 (range 0, 8) (table 2).  
DRI and pain intensity 12 weeks postpartum had a median value of 5 (IQR 20) and 0 
(IQR 12) respectively and were significantly correlated (rs=0.63, p<0.001). The correlation 
coefficients between DRI and the potential risk factors ranged from -0.01 to 0.28 and, 
between pain intensity and the potential risk factors from -0.08 to 0.34 (table 3). The 
correlation coefficients between the potential risk factors did not suggest collinearity (range -
0.28 to 0.36). The only exception from this was a correlation coefficient of 0.75 between the 
P4 test and sum of pain provocation tests. 
Marital status, education, smoking, pre-pregnancy physical activity, and HSCL-25 
were not significantly associated with either DRI or pain intensity12 weeks postpartum in the 
bivariate analysis (0.56≤p≤0.81) (table 3). These variables were not entered in the respective 
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multivariable models. Age and parity were not significantly associated with any of the 
response variables (0.31≤p≤0.88) and pre-pregnancy LBP was not associated with pain 
intensity (p=0.50) (table 3). Yet these variables were entered in the multivariable models 
based on previous studies (Berg et al., 1988; Ostgaard et al., 1991; Kristiansson et al., 1996; 
Hansen et al., 1999; Mogren and Pohjanen, 2005; Albert et al., 2006). Pain locations were not 
associated with DRI (p=0.15) and the ASLR test was not significantly associated with pain 
intensity (p=0.07). Yet, these variables were entered in the multivariable models based on the 
hypothesis and previous studies (Albert et al., 2001; Vollestad and Stuge, 2009; Robinson et 
al., 2010b). 
 In the multivariable model, pre-pregnancy LBP and sum of pain provocation tests 
were significantly associated with DRI 12 weeks postpartum (table 4). Pre-pregnancy BMI 
and the ASLR test were also associated with DRI, though not significantly (0.05≤p≤0.07) 
Age, parity, pain locations, P4 test and number of pain sites were not significantly associated 
with DRI (0.23≤p≤0.88) and were not included in the final model. R2 was 0.18. No significant 
interactions were found between the explanatory variables (0.19≤pinteraction≤0.93).   
In the multivariable model, the number of pain sites and the sum of pain provocation 
tests were significantly associated with pain intensity 12 weeks postpartum (table 5). Pre-
pregnancy BMI was associated with pain intensity, though not significantly (p=0.05). Age, 
parity, mFABQ, pain locations, P4 and the ASLR test were not significantly associated with 
pain intensity (0.18≤p≤0.75) and were not included in the final model. R2 was 0.16. No 
significant interactions were found between the explanatory variables (0.06≤pinteraction≤0.87).  
The analyses were repeated with pain intensity and DRI ln transformed. The same risk 
factors were identified but the p-values were somewhat changed (table 4 and 5). 
Because the P4 test and the sum of pain provocation tests were strongly correlated (rs= 
0.75), the analyses were repeated with both variables in the model as well as with each one 
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separately. The results consistently showed that the P4 test was not significantly associated 
with either DRI or pain intensity 12 weeks postpartum (0.14≤p≤0.80).   
 The same explanatory variables as used in the analyses above were also entered into a 
logistic regression model with non-recovery 12 weeks postpartum as the response variable. 
Number of pain sites and sum of pain provocation tests were significantly associated with 
non-recovery (table 6). Pre-pregnancy BMI was also associated with non-recovery, though 
not significantly (p=0.05). The odds increased with increased number of pain sites and OR 
was 4.4 (95% CI (1.3, 14.6)) for women with 3-4 pain sites as compared to women with no 
pain sites in the adjusted analyses. Moreover, OR=3.5 (95% CI (1.2, 10.3)) for women with 6-
8 positive provocation tests as compared to women with 0-1 positive test.   
 
Discussion 
To our knowledge, this is the first study that includes both socio-demographical and 
psychological factors together with results of clinical tests in multiple regression models, to 
identify risk factors for disability and pain intensity 12 weeks postpartum. Our results showed 
that a high number of positive pain provocation tests was a significant risk factor for both 
disability and pain intensity measured by graded scales 12 weeks postpartum. Furthermore, a 
high number of pain sites was a significant risk factor for pain intensity. When we used the 
dichotomous variable for non-recovery as response in a multiple logistic regression analysis, 
the sum of pain provocation tests and number of pain sites were significant risk factors. Hence 
the results were quite consistent.  
The outcome variables used in the present study differ from what have previously 
been used. Croft has recently recommended graded scales (Croft, 2009), and in accordance 
with this we used DRI and pain intensity as measures of affliction. Also when defining the 
dichotomous response variable for the logistic regression analysis both pain and disability was 
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included. Hence the outcomes used in both regression models were based on affliction levels 
and not simply the presence of PGP.   
The present study identified two pain related risk factors. Sum of pain provocation 
tests are supposed directly related to the pelvis and the number of positive tests may thus be 
assumed to reflect severity of PGP. Hence, it seems that the affliction level of the pelvis itself 
is important for the degree of recovery postpartum. The other pain related factor, number of 
pain sites, reflects affliction in other areas of the body. Although only four areas were 
included in the questionnaire, the number of pain sites in pregnancy was associated with pain 
intensity and non-recovery postpartum. This finding is in keeping with a prospective study of 
patients with LBP showing that widespread pain was a risk factor of persistent disabling LBP 
(Thomas et al., 1999). Furthermore, it has also been shown in a population based study that 
the number of pain sites is a predictor of work disability (Kamaleri et al., 2009). Hence, it 
seems that widespread pain is a common risk factor for different groups, including those 
seeking health care and those less afflicted.  
The functional ASLR test was associated with DRI 12 weeks postpartum though not 
significant. It has been suggested that the ASLR test can assess disease severity in patients 
with PGP postpartum (Mens et al., 2002), and that there is an association between the ASLR 
test and mobility in the pelvic joints (Mens et al., 1999), but the evidence for these 
associations is weak. We have previously shown that the ASLR test was associated with 
disability, when both factors were measured in gestation week 30 (Robinson et al., 2010a). 
However, little is known about the relationship between the ASLR test and recovery or 
improvement in function, although a relationship could be expected.  
Interestingly, the P4 test was not associated with either disability or pain intensity 12 
weeks postpartum. Even though it has been identified as a risk factor for the development of 
PGP in pregnancy (Robinson et al., 2010a), the P4 test seems to be of negligible importance 
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for the prognosis. The P4 and the ASLR test thus seem to differ in their ability to predict the 
development of PGP in pregnancy and prognosis postpartum. This suggests that the P4 and 
the ASLR test reflect different aspects of PGP.  
Previous studies have shown that pain location was risk factors for sustained PGP after 
delivery (Albert et al., 2001; Gutke et al., 2008; Vollestad and Stuge, 2009). Our analyses 
with graded scales could not verify these results. Furthermore, logistic regression analyses, 
using dichotomous responses gave the same result. Hence the inclusion of clinical tests seems 
to abolish possible effects of pain locations. 
Age, parity, pre-pregnancy BMI and pre-pregnancy LBP have been associated with 
sustained PGP postpartum in previous studies using bivariate statistics (Ostgaard and 
Andersson, 1992; Turgut et al., 1998; To and Wong, 2003; Albert et al., 2006) or 
multivariable models (Breen et al., 1994; Mogren, 2006; Rost et al., 2006). In the present 
study, pre-pregnancy BMI was associated with both DRI and pain intensity, but not 
significantly. Pre-pregnancy LBP was identified as a risk factor for disability. Different 
terminology and definitions, as well as lack of multivariable analyses in previous studies 
make further comparisons difficult.  
Apart from the sum of pain provocation tests, the risk factors for sustained disability 
and pain intensity postpartum differ from the risk factors identified for development of 
disability and pain intensity during pregnancy (Robinson et al., 2010b). The difference 
indicates that the underlying processes for development and prolongation of PGP postpartum 
are different.    
 
Conclusions 
This study shows that results of clinical examinations and tests in late pregnancy are 
significant risk factors for disability and pain intensity 3 months postpartum, even when 
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controlling for socio-demographical and psychological factors. The clinical tests used in this 
study are easy to perform, and the results are of clinical importance because they seem to have 
the potential to identify women with a poor prognosis. It will be of interest to examine if the 
clinical factors also represent a risk for pelvic girdle pain and disability when the follow-up 
period is extended. Furthermore, the clinical risk factors should be used as basis for 
development of strategies for management of women at risk for sustained PGP postpartum. 
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Figure 1 
  
104 women not afflicted 
with PGP 
385 eligible pregnant women from 4 Maternity Care Units 
59 denied participation 
326 women included, 
questionnaire and clinical 
examination 
 
9 miscarriages and 3 
drop outs 
Gestation week 30:  
283 women met for a new 
clinical examination 
12 weeks postpartum:  
179 women defined as 
afflicted in gestation week 
30, answered questionnaire 
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Table 1 Characteristics of the participants (n=179) 
 
  Frequency (%) Mean (SD) 
Age (years)   31 (4) 
Parity  0 98 (55)  
 1 64 (36)  
 ≥2  17 (9)  
Marital status (single)  7 (4)  
Education ≤ 12 years school attendance 36 (20)  
 ≤4 years university 73 (41)  
 >4 years university 70 (39)  
Smoking (yes)  9 (5)  
Pre-pregnancy BMI (kg/m2)   23.5 (3.7) 
Pre-pregnancy physical activity  None 7 (4)  
 < 2 hours per week 56 (31)  
 2 - 4 hours per week 90 (50)  
 > 4 hours per week 25 (14)  
Pre-pregnancy history of LBP (yes)  90 (50)  
mFABQ  (0-24)   12.0 (4.2)  
HSCL-25 (score ≥1.75)  29 (16)  
 
 
BMI, Body Mass Index; LBP, Low Back Pain; mFABQ, modified Fear Avoidance Beliefs questionnaire; HSCL-
25, Hopkins Symptom Check List 
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Table 2 Pain locations and clinical tests in gestation week 30 and DRI and pain intensity 12 weeks postpartum. 
(n=179) 
   Frequency (%) Median 
(range) 
Pain locations No pain  3 (2)  
 Pain in symphysis only  12 (7)  
 Posterior pain only  99 (55)  
 Combined symphysis 
and posterior pain 
 65 (36)  
Pain provocation 
tests 
    
 Distraction test Negative 83 (46)  
  Positive 96 (54)  
 Compression test Negative 125 (70)  
  Unilateral positive 33 (18)  
  Bilateral positive 21 (12)  
 Patrick-Faber test Negative 54 (30)  
  Unilateral positive 51 (29)  
  Bilateral positive 73 (41)  
 Palpation of pubic 
symphysis 
 
Negative 
 
148 (83) 
 
  Positive 30 (17)  
 Palpation of LDL Negative 50 (29)  
  Unilateral positive 44 (25)  
  Bilateral positive 81 (45)  
 Sum of pain 
provocation tests (0, 8) 
  4 (0, 8) 
 P4 test Negative 41 (23)  
  Unilateral positive 30 (17)  
  Bilateral positive 108 60)  
Functional test     
 ASLR test (0, 10)   3 (0, 10) 
Number of pain sites  0 92 (51)  
  1 44 (25)  
  2 25 (14)  
  3 14 (8)  
  4 4 (2)  
 
LDL, Long Dorsal Sacroiliac Ligament; P4 test, Posterior Pelvic Pain Provocation test; ASLR test, Active 
Straight Leg Raise test 
 24 
Table 3. Correlation between outcome variables (DRI and evening pain 12 weeks after delivery) and risk factors 
measured in pregnancy (n=179) 
 
  
DRI 12 weeks 
postpartum 
 
Evening pain 12  
weeks postpartum 
Evening pain 12 weeks postpartum 0.63***  
Age (years) -0.01 -0.07 
Parity (0, 1, ≥2) -0.07 -0.08 
Marital status (married or cohabitant; yes, no) 0.02 -0.12 
Education (≤12 years of school attendance , ≤4 years university, 
>4 years university) 
-0.05 -0.09 
Smoking (yes, no) 0.13 0.08 
Pre-pregnancy BMI (kg/m2) 0.20* 0.17* 
Pre-pregnancy physical activity (none, <2, 2-4, >4 hours per 
week) 
0.02 0.09 
Pre-pregnancy LBP (yes, no) 0.20* 0.09 
mFABQ (0-24) 0.17* 0.21* 
HSCL-25 (<1.75, ≥1.75) 0.10 0.15 
Pain locations (no pain, symphysis pain, posterior pain, combined 
symphysis and posterior pain) 
0.11 0.17* 
Sum of pain provocation tests (0-8) 0.28** 0.34*** 
P4 test (bilateral negative, uni-/bilateral positive) 0.20* 0.23** 
ASLR test (0,>0) 0.23** 0.14 
Number of pain sites (0-4) 0.24** 0.34*** 
 
Spearman’s correlation coefficient; ***p≤0.001, **0.001<p≤0.01 *0.01<p≤0.05  
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 Table 4 Associations between DRI 12 weeks postpartum and pre-pregnancy BMI, pre-
pregnancy LBP, sum pain provocation tests and the ASLR test, the two latter factors were  
measured in gestation week 30 (n=179). P-values after ln transformation of DRI are also 
given. 
 
 DRI Ln transformed 
DRI 
 Crude estimates Adjusted estimates3  
 β1 (95% CI2) p-value β1 (95% CI2) p-value p-value 
Pre-pregnancy BMI       
 <25 kg/m2 Reference 0.03 Reference 0.07 0.08 
≥25 kg/m2 5.6 (0.5, 10.6)  4.6 (-0.3, 9.5)   
Pre-pregnancy LBP      
No Reference 0.04 Reference 0.03 0.01 
Yes 5.0 (0.3, 9.8)  5.0 (0.5, 9.5)   
Sum pain provocation tests       
0-1 pos tests Reference <0.001 Reference 0.03 0.05 
2-3 pos tests 3.4 (-1.7, 10.5)  1.0 (-6.2, 8.3)   
4-5 pos tests -1.7 (-4.8, 8.1)  -0.4 (-6.9, 6.2)   
6-8 pos tests 12.0 (5.7, 18.3)  7.7  (1.1, 14.3)   
ASLR      
0 Reference 0.005 Reference 0.05 0.03 
>0 7.6 (2.3, 12.9)  5.4 (-0.1, 10.9)   
 
Multiple linear regression analysis 
1 Estimated regression coefficients, 2 CI, confidence interval, DRI, Disability Rating Index.  
3 Adjusted for the other variables in the table; BMI, body mass index; ASLR test, Active 
Straight Leg Raise test;    
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Table 5 Associations between pain intensity 12 weeks postpartum and pre-pregnancy BMI, 
sum of pain provocation tests and number of pain sites (n=179). The two latter factors were 
measured in gestation week 30. P-values after ln transformation of pain intensity are also 
given. 
   
 Pain intensity Ln transformed 
pain intensity 
 Crude estimates  Adjusted estimates3  
 β1 (95% CI2) p-value β1 (95% CI2) p-value p-value 
Pre-pregnancy BMI      
<25 kg/m2 Reference 0.02 Reference 0.05 0.007 
≥25 kg/m2 8.8 (1.5, 15.1)  5.7 (-0.3, 11.8)   
Number of pain sites      
0 Reference 0.03 Reference 0.007 0.001 
1 3.9 (-3.5, 11.4)  1.5 (-5.9, 9.0)   
2 9.9 (0.4, 19.3)  8.8 (-0.5, 18.2)   
3-4 21.5 (10.7, 32.3)  18.7 (7.9, 29.6)   
Sum pain provocation tests      
0-1 pos tests Reference 0.006 Reference 0.04 0.001 
2-3 pos tests 5.7 (-4.1, 15.5)  2.3 (-7.4, 11.9)   
4-5 pos tests 5.4 (-3.5, 14.3)  1.3 (-7.4, 10.1)   
6-8 pos tests 15.1 (6.4, 23.8)  11.2 (2.4, 19.8)   
 
Multiple linear regression analysis 
1 Estimated regression coefficients, 2 CI, confidence interval, DRI, Disability Rating Index. 
3 Adjusted for the other variables in the table; BMI, body mass index 
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Table 6 Crude and adjusted odds ratios with 95% confidence intervals for non-recovery 12 
weeks postpartum due to pre-pregnancy BMI, number of pain sites and sum of pain 
provocation tests measured in gestation week 30. 
 
  Crude estimates  Adjusted estimates3  
  β1 (95% CI2) p-value β1 (95% CI2) p-value 
Pre-pregnancy BMI <25 kg/m2 1.0  1.0  
 ≥25 kg/m2 2.2 (1.1, 4.4) 0.03 2.1 (1.0, 4.5) 0.05 
Number of pain sites 0 1.0  1.0  
 1 2.8 (1.2, 6.2) 0.01 2.3 (1.0, 5.5) 0.05 
 2 2.3 (0.8, 6.4) 0.1 2.0 (0.7, 5.7) 0.21 
 3-4 5.2 (1.7, 15.9) 0.004 4.4 (1.3, 14.6) 0.02 
Sum pain provocation 
tests 
0-1 pos tests 1.0  1.0  
 2-3 pos tests 1.7 (0.5, 5.5) 0.40 1.2 (0.3, 4.0) 0.82 
 4-5 pos tests 1.5 (0.5, 4.4) 0.51 1.0 (0.3, 3.3) 0.94 
 6-8 pos tests 5.0 (1.8, 14.0) 0.002 3.5 (1.2, 10.3) 0.02 
 
Multiple logistic regression analysis 
1 Estimated regression coefficients, 2 CI, confidence interval, DRI, Disability rating Index  
3 Adjusted for the other variables in the table; BMI, body, mass index 
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UNIVERSITETET I OSLO, 
Seksjon for helsefag, 
Postboks 1153 Blindern, 
0318 Oslo 
 
FORESPØRSEL OM DELTAGELSE I FORSKNINGSPROSJEKT: 
KVINNERS PLAGER OG FYSISKE FUNKSJON UNDER OG ETTER 
SVANGERSKAP 
 
Det har tidligere vært gjennomført flere helseundersøkelser i befolkningen, men få har 
fokusert på kvinner under og etter svangerskap. Seksjon for helsefag ved Universitetet i Oslo i 
samarbeid med Gamle Oslo helsestasjon og helsestasjonene i Oppegård, er nå i gang med en 
undersøkelse av kvinners plager og fysiske funksjon under og etter svangerskap. For å få vite 
noe om dette spør vi deg om du kan tenke deg å delta.  
Undersøkelsen er en del av et doktorgradsarbeid ved Universitetet i Oslo.  
 
Praktisk gjennomføring. 
Kvinner som skal gå til svangerskapskontroll ved Gamle Oslo helsestasjon og helsestasjonene 
i Oppegård, blir bedt om å delta i prosjektet. Deltagelse medfører at du må svare på et 
spørreskjema tre ganger underveis i svangerskapet samt to ganger i løpet av de tre første 
månedene etter fødsel. Det er derfor nødvendig at du behersker norsk språk både muntlig og 
skriftlig. Innholdet i disse skjemaene dreier seg om din helse og fysiske funksjon samt om 
eventuelle smerter eller plager som du opplever underveis i svangerskapet. Utfyllingen av det 
første spørreskjemaet tar en drøy halv time, de resterende vil ta noe kortere tid. Ved første 
gangs kontroll på helsestasjonen ønsker vi å ta en blodprøve av deg. Denne blodprøven 
benyttes til å undersøke innholdet av et hormon (relaxin), som er relatert til svangerskap. 
Dette hormonet kan være med å påvirke bevegelighet og funksjon hos gravide.  
 
I tillegg ber vi om at en fysioterapeut får lov til å undersøke deg to ganger mens du er gravid 
samt en gang tre mnd etter fødsel. Dette innebærer at vi tester ut hvor bevegelig du er i 
leddene dine, om du har noen smerter fra korsrygg og bekken og hvordan du utfører enkle 
funksjonsprøver. Selve undersøkelsen vil vare ca en halv time hver gang. 
 
Det er frivillig å delta. 
Du kan trekke deg fra prosjektet når som helst, uten å oppgi noen grunn, og det får ingen 
konsekvenser for deg eller for dine videre kontroller på helsestasjonen. Hvis du skulle trekke 
deg fra prosjektet så vil dine data bli anonymisert, og blodprøven din blir destruert. 
Prosjektet er meldt til personvernombudet for forskning, Norsk Samfunnsvitenskapelig 
datatjeneste. 
 
Din sikkerhet. 
Alle undersøkelser som benyttes er kjente og godt etablerte og benyttes daglig i undersøkelse 
og behandling av gravide kvinner. Alle opplysninger vil være konfidensielle og bare brukes så 
lenge prosjektet pågår. Opplysningene du gir oss oppbevares slik at de ikke kan kobles til deg.  
 
Blodprøven din vil bli avidentifisert og sendt til Hormonlaboratoriet ved Aker 
Universitetssykehus hvor den analyseres og lagres i en biobank. Denne forskningsbiobanken 
er godkjent opprettet av Sosial- og helsedirektoratet. 
 
Prosjektet planlegges å være ferdig 31. desember 2009. Etter avslutning vil de innsamlede 
dataene oppbevares, men uten at deltagerne kan identifiseres. Avhengig av resultatene vi får, 
kan det hende at vi kontakter deg igjen og spør om du kan tenke deg å svare på noen flere 
spørsmål. Vi understreker at det er frivillig å være med på en eventuell oppfølging og at du 
kan takke nei til dette. Hvis du ikke har blitt kontaktet igjen før prosjektet er avsluttet 
(31.12.09), vil datamaterialet uansett bli anonymisert og blodprøvene destruert. 
 
Prosjektet er tilrådd av Regional komité for medisinsk forskningsetikk (REK). 
 
Dersom du har noen spørsmål er du velkommen til å ta kontakt med meg eller jordmor på 
helsestasjonen. Jeg kan nås på følgende telefon nummer, 22858421, mobil: 90607081 (med 
telefonsvarer). Informasjon om prosjektet finnes også på internett: http:/folk.uio.no/hildesr  
 
Med vennlig hilsen 
 
Hilde Stendal Robinson 
Prosjektleder, doktorgradsstipendiat 

Informert samtykke. 
Jeg har mottatt skriftlig og muntlig informasjon, og jeg er villig til å delta i prosjektet 
”Kvinners plager og fysiske funksjon under og etter svangerskap”. 
 
Jeg har forstått at deltagelsen er frivillig, og at jeg når som helst kan trekke meg fra 
undersøkelsen uten å oppgi noen grunn.  
 
 
 
…………………………..    …………………. 
Sted       dato 
 
 
 
………………………………………………… 
  Signatur 
 
 
 
 
